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SUMMARY 
 
As a member of NIMA-related kinase family (Nrk), Nek8 has an N-terminal 
serine/threonine kinase domain highly homologous with that of NIMA. Most of the 
NIMA-related kinase family members are involved in cell cycle regulation. Roles of 
Nek8 in cell cycle and other cellular regulation are very little known. Nek8 is only 
shown to be related to kidney disease. Therefore, the main purpose of the studies in 
this thesis was to explore Nek8’s functions in cellular regulation.  
Nek8 contains an N-terminal catalytic domain and a C-terminal RCC1-like 
domain. We are the first to identify a small GTPase Ran and a chaperone protein 
hsp70 as binding partners of Nek8. We demonstrate that Nek8 is not an essential cell 
cycle regulator as most of its family members, in that overexpression of Nek8 has 
little effect on changing cell cycle progression. We also found that Ran can interact 
with Nek8 and facilitate translocation of Nek8 between cytoplasm and nucleus, 
suggesting Nek8 may be involved in the process of nuclear transport. 
Furthermore, the cellular localization of Nek8 in the endoplasmic reticulum (ER) 
and its role in delaying apoptosis induced by the ER stress drugs indicate that Nek8 
could be responsible for protecting cells from ER stress-induced apoptosis. We found 
that Nek8 could interact with Hsp70. Hsp70 can enhance cell survival under several 
lethal conditions and has been revealed to negatively regulate the mitochondrial 
pathway of apoptosis. Thus it is possible that protection of cells from ER 
stress-induced apoptosis by Nek8 is due to the association of Nek8 with Hsp70. 
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ER stress has been associated with a wide range of diseases, including 
neurodegeneration, cardiac disease, cancer and diabetes. Nek8 itself has been known 
to be linked with some diseases, such as cancer and kidney disease. Defects in Nek8 
gene can cause polycystic kidney disease (PKD). Nek8 was reported to regulate cilia 
formation. The mutations in Nek8 may affect its ciliary localization. The observation 
that jck mice have longer cilia than wild-type mice indicates that Nek8 may control 
the cilia length. However the detailed mechanism under this disease is not clear. Our 
observation of Nek8’s role to protect cells from apoptosis induced by ER stress could 
provide a new direction for study on Nek8 in the kidney disease and cancers.  
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1.1 Introduction of the NIMA-related kinase family 
Proteins are large molecules made of amino acids. They are essential parts of 
organisms and participate in all processes within cells. Among them, a type of the 
enzymes called protein kinases can catalyze phosphorylation. Phosphorylation is the 
process to introduce a phosphate (PO4) group to a protein or a small molecule. This 
process is an essential regulatory event in eukaryotes. Phosphorylation can result in 
functional changes of the target substrate, by changing its enzyme activity, cellular 
localization or association with other proteins (Murray 1991). Through 
phorsphorylation, the protein kinases can regulate a majority of cellular events 
including cell growth, cell cycle, movement and death. Deregulation of the protein 
kinases could cause diseases, such as cancer. Thus research on protein kinases will 
help us to know more about the mechanism of cancer and provide useful clues for 
drugs designed to treat cancer and other diseases (Manning et al. 2002).  
The chemical activity of a kinase involves covalent attachment of the phosphate 
group to one of three amino acids with a free hydroxyl group. These three amino acids 
are serine, threonine and tyrosine. Based on this binding property, protein kinases can 
be separated into several subsets: serine/threonine-specific protein kinases, 
tyrosine-specific protein kinases and serine/threonine-tyrosine mixed kinases, etc. 
Among them, serine/threonine kinases are the most important ones and they are 
involved in many cellular regulation events (e.g. cell cycle regulation). Cell cycle is a 
series of events in a eukaryotic cell leading to its replication. These events can be 
divided into two broad periods: interphase (including G1, S and G2 phase) and mitotic 
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(M) phase. During cell cycle, mitotic phase is the crucial phase at which one cell splits 
into two identical ones. The process of mitosis is complex and highly regulated. 
Errors in this process can be especially dangerous to the organism because the future 
offspring from the parent cell will carry the same disorder. Several key regulators of 
mitosis are serine/threonine kinases that are responsible for modulating the whole 
process throughout the mitosis. One of the serine/threonine kinases is cdc2, which is 
on the very upstream of the phosphorylation cascade in mitosis (Nigg 2001). There 
are three major protein kinase families regulating downstream events following Cdc2 
activation: Aurora, Polo-like and NIMA-related kinases. The first two have been well 
studied and found to regulate many events in mitosis (Andrews et al. 2003; Seeburg et 
al. 2005; Takai et al. 2005), while the third protein family, NIMA-related kinases, is 
less well understood and recently many researchers have turned to focus on this 
kinase family.  
 
1.1.1 NIMA-related kinases (Nrks) in different biological systems  
The NIMA-related protein family is named from the protein NIMA (Never In 
Mitosis A), which is a serine/theronine kinase first identified in Aspergillus nidulans 
encoded by nimA gene. Mutation in nimA gene can arrest cells in G2 and excess nimA 
can initiate mitosis, suggesting that the NIMA protein has a crucial role in the G2/M 
transition (Osmani et al. 1987; Osmani et al. 1988). Since protein level of NIMA in 
mitosis is much higher than that in other cell cycle stages, the regulation of NIMA 
shows a cell cycle-dependent manner. Moreover, if the G2 arrest of nimA mutants is 
                                                                          Chapter 1 Introduction                    
                                              4
bypassed by additional mutants, the cells will show incomplete mitosis with aberrant 
spindle and nuclear envelope organization, which means that NIMA may function 
more than as the control of mitotic entry (Osmani et al. 1991). NIMA is also shown to 
be phosphorylated and activated by cdc2/cyclin B complex, which initiates mitosis. 
Degradation of NIMA in late mitotic stage is important for mitosis exit (Ye et al. 
1995). Overexpression of NIMA in mammalian cells can induce chromatin 
condensation and nuclear breakdown as it does in Aspergillus (O'Connell et al. 1994), 
leading to the hypothesis that proteins with similar NIMA kinase domain in 
eukaryotes can also regulate the cell cycle. Homology-based screens for nimA genes 
in eukaryotic cells have uncovered a large family of genes encoding the 
NIMA-related kinases (Nrk).  
NIMA homologs have been found in several biological systems, such as in S. 
cerevisiae, Neurospora crassa, fission yeast, tetrahymena, Xenopus and the human 
parasite Plasmodium falciparum (Schweitzer and Philippsen 1992; Pu et al. 1995; Fry 
et al. 2000; Dorin et al. 2001). Nek1, Nek2 and Nek3 were the first three mammalian 
homologs of NIMA found in mouse (Ben-David et al. 1991; Letwin et al. 1992; 
Schultz et al. 1994; Chen et al. 1999). Figure 1.1 shows the schematic map of the 
NIMA related kinase family (O'Connell et al. 2003). These Nrk family members share 
an N-terminal catalytic domain which is highly similar to the kinase domain of NIMA. 
In addition, in term of function, most of the family members are cell cycle-related 
kinases similar to NIMA. Some family members work as mitotic regulators as NIMA, 
such as the S. pombe homology FIN1. Overexpression of Fin1 can lead to premature 
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chromosome condensation while this condensation is cdc2-independent (Krien et al. 
1998). The presence of different functional domains in the C-terminus of Nrks 
suggests divergent functions in addition to regulation of mitotic entry. This hypothesis 
has been supported by several reports on the functional study of Nrks. More evidences 
found in mammalian Nrks will be demonstrated in chapter 1.1.2.  
                                                                          Chapter 1 Introduction                    




Figure 1.1 Molecular strucutures of NIMA-related kinase (Nrk) family members  
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1.1.2 Human NIMA-related kinases (Neks) and their roles in cellular 
regulation 
Researchers paid more attention on the mammalian NIMA family members 
recently. So far, at least twelve NIMA-related protein kinases, named as Neks 
(Nek1-Nek12), have been identified in human genome (O'Connell et al. 2003).   
Among these human NIMA-related kinases, Nek2 is closest to NIMA with 44% 
identical sequence in the kinase domain (Fry 2002). Nek2 has two spliced isoforms: 
Nek2A and Nek2B. Their molecular structures are shown in Figure 1.1. Nek2A has an 
N-terminal kinase domain, a leucine zipper and a C-terminal regulatory domain with 
motifs for APC/C-mediated destruction and interaction with PP1c, the catalytic 
subunit of protein phosphatase 1 (PP1) (Hayes et al. 2006). Nek2B lacks the 
coiled-coil domain in the C-terminal region compared with Nek2A (Uto et al. 1999). 
In adult human cells, both Nek2 isoforms can be detected while Nek2A is more 
abundant. However, in eggs and early embryos of Xenopus, only Nek2B can be 
detected (Uto et al. 1999). Nek2 is strictly cell cycle-regulated as NIMA but has 
expression patterns different from NIMA (Schultz et al. 1994). Expression of Nek2 
protein is low during G1. Both the spliced isoforms increase approximately four fold 
at G1/S transition and this high level expression remains during S and G2 phases. 
During mitosis, Nek2A decreases while Nek2B remains the same protein level as in 
the S and G2 phases. Nek2 can be localized in centrosome throughout the cell cycle, 
and has functions in mitosis because it is responsible for chromosome stability (Fry 
2002). Depletion of Nek2A or overexpression of the active Nek2A can lead to 
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abnormal chromosome separation (Fry et al. 1998). Nek2 has been reported to be 
involved in several mitotic events such as chromatin condensation, cytokinesis and 
mitotic exit (Hayward and Fry 2006). Moreover, upregulation of Nek2 can be 
detected in cancer cells, suggesting that Nek2 could be a potential drug target for 
controlling cancer. In addition, Nek2 can dimerize through its C-terminal leucine 
zipper coiled-coil domain and the dimerization is essential for its kinase activities and 
cellular effects (Fry et al. 1999). Nek2 is activated by phosphorylation on its 
activation loop at Thr175 and this phosphorylation can be reverted by PP1-mediated 
dephosphorylation. The crystal structure of the complex containing Nek2 kinase 
domain and a pyrrole-indolinone inhibitor has been resolved (Rellos et al. 2007). The 
crystal structures of wildtype Nek2 kinase domain mutant bound to ADP and T175A 
mutant in apo form have also been reported (Westwood et al. 2009). The results 
showed that the regions of Nek2 structure around the nucleotide-binding site can 
adopt different conformations. The mechanism of the auto-inhibition of Nek2 indeed 
provide insights in designing potential specific inhibitors of Nek2 and drug therapy in 
the future (Westwood et al. 2009).   
Nek1 is the first identified mammalian NIMA homolog (Letwin et al. 1992). It 
can phosphorylate β-casein in vitro. Although Nek1 is a cytoplasmic protein, 
overexpression of nuclear construct of Nek1 can cause defect in chromosome 
condensation (Feige et al. 2006). It appears that Nek1 may be involved in mitotic 
regulation but not essential. Mutation of Nek1 was detected in mice with polycystic 
kidney diseases (PKD) (Upadhya et al. 2000). Subsequently, Nek1 was reported to be 
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related to PKD through regulating primary cilia formation and centrosome stability 
(Shalom et al. 2008; White and Quarmby 2008). Nuclear localization signals (NLS) 
and nuclear export signals (NES) were identified in Nek1. Nek1 was shown to export 
from the nucleus via a NES-dependent pathway. The cycles of Nek1 in and out of 
nucleus have also been demonstrate (Hilton et al. 2009). Combined with the functions 
of Nek1 in ciliogenesis, these results suggest that Nek1 can deliver messages from the 
ciliary-basal body region to the regulation of nuclear gene expression (Hilton et al. 
2009). Although mainly located in cytoplasm, a fraction of Nek1 can also be found to 
fractionate and locate in mitochondria. Nek1-deficient fibroblasts are more sensitive 
to the effects of ionizing radiation (IR)-induced DNA damage than the wildtype Nek1 
(Polci et al. 2004). Moreover, Nek1 can respond to several different types of damage 
in addition to IR. Further research suggests that Nek1 functions in G1/S checkpoint 
control (Chen et al. 2008). Latest study shows that Nek1 can be involved in 
mitochondrial cell death through phosphorylation of voltage dependent anion channel 
1 (VDAC1) (Chen et al. 2009).  
Similar to Nek1, Nek3 is also a cytoplasmic protein. In addition to N-terminal 
catalytic domain homologous to NIMA, Nek3 has two PEST (proline-, glutamate-, 
serine- and theronine-rich) domains at its C terminus. Inhibition of Nek3 activity does 
not affect cell cycle progression, suggesting that Nek3 may not function in cell cycle 
regulation (Tanaka and Nigg 1999). Relatively high expression level of Nek3 can be 
found in neurons from the central and peripheral nervous systems. Further study 
shows that Nek3 can regulate microtubule acetylation in neurons. Phosphorylation of 
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Thr475 in Nek3, which is located in the PEST domain, can serve as a regulator switch 
that alters Nek3’s functions in neurons (Chang et al. 2009).  
Nek6 is also a mitotic kinase regulating chromosome condensation and is 
involved in DNA damage checkpoint (Belham et al. 2001; Lee et al. 2008). 
Overexpression of kinase-dead Nek6 leads to prometaphase-metaphse arrest (Yin et al. 
2003). Several substrates of Nek6 have been identified. Pin1 can associate with Nek6 
and they are both highly expressed at mRNA level in patients with hepatocellular 
carcinoma (Chen et al. 2006). Nek6 also binds to Fe65 and this complex may be 
involved in apoptosis (Lee et al. 2007). Latest research showed that Nek6 can bind 
and phophorylate Eg5 (Kinesin-5) at C-terminal site. This phosphorylation occurs in a 
small fraction of total spindle-associated Eg5, and it is required for normal Eg5 
function in spindle bipolarity (Rapley et al. 2008). Nek7 is also critical for 
microtubule nucleation and in cytokinesis (Kim et al. 2007). Overexpression of 
wildtype or kinase-dead Nek7 leads to increased multinuclear and apoptotic cells 
(Yissachar et al. 2006). Recent studies further revealed that both Nek6 and Nek7 are 
required for mitotic spindle formation and cytokinesis because depletion of either 
Nek6 or Nek7 can cause defective mitotic progression (O'Regan and Fry 2009). 
Nek6 and Nek7 can be activated by Nek9 (also known as Nercc1) and an 
auto-inhibitory tyrosine motif in Nek7 can be released after binding to Nek9 (Belham 
et al. 2003; Richards et al. 2009). Nek9 was first isolated as a β-casein kinase from 
rabbit lung (Holland et al. 2002). Its human homolog gene was then identified 
(Holland et al. 2002). Human Nek9 protein contains 979 amino acids with a 
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molecular weight of 123kDa. It was previously named as Nek8, later renamed as 
Nek9 or Nercc1. The central part of Nek9 protein structure is a region containing 
repetitive motifs similar to those found in RCC1 protein-the regulator of chromosome 
condensation, which is called RCC1-like domain. Moreover, there is a coiled-coil 
domain at the C terminus of Nek9 (Roig et al. 2002). The biochemical characteristics 
of Nek9 have been examined. Like some other NIMA-related kinases, Nek9 prefers to 
phosphorylate β-casein than other exogenous substrates and even has the ability of 
autophosphorylation (Roig et al. 2002). Autophosphorylation of Nek9 is Mg2+-ATP 
dependent in vitro and requires phosphorylation of active loop at Thr210. During this 
process, GTP can be used as phosphate donor (Belham et al. 2003). Further study 
indicates that Nek9’s autophosphorylation leads to its homodimerization through the 
coiled-coil domain. The kinase activity of Nek9 is not cell cycle-regulated, but its 
protein level is consistently high in G0-arrested cells. 
Some binding targets of Nek9 have been identified (Roig et al. 2002; Belham et 
al. 2003). As mentioned above, Nek9 can phosphorylate Nek6/Nek7 and activate their 
functions in cell cycle regulation (Belham et al. 2003). During mitosis, the activity of 
Nek6 increases and this activation requires phosphorylation of Ser206 on the activity 
loop of Nek6. In vitro studies showed that Nek9 can directly catalyze the activity of 
recombinant Nek6 on Ser206. Similar results can be observed in the case of Nek7. 
Based on these results, it is likely that Nek9 and Nek6/7 represents a novel cascade of 
mitotic protein kinases whose combined functions will be important for mitotic 
progression. Other than binding to members from the same protein family, Nek9 can 
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bind specifically to Ran GTPase through the RCC1-like domain. Nek9 can also bind 
to Ran through its catalytic domain (Roig et al. 2002). As a small GTPase, Ran has 
two different nucleotide-bound forms, RanGTP and RanGDP. Nek9 prefers to bind to 
RanGDP in vivo. To date, the biological functions of the interaction between Nek9 
and Ran are not clear. Nek9 is an exclusively cytoplasmic protein unlike NIMA, but it 
is still activated during mitosis and phosphorylated by active cdc2. Microinjection of 
anti-Nek9 antibody into cells at prophase results in spindle abnormalities and 
chromosome misalignment, suggesting that Nek9 is also a mitotic spindle regulator 
(Roig et al. 2002). Although Nek9 was regarded as a cytoplamsic protein, it can 
associate with adenovirus E1A, which is a nuclear protein. The Nek9 mutant without 
RCC1-domain can stably associate with E1A and remain its localization in nucleus. 
All these results suggest that E1A may direct the cellular distribution of Nek9 (Pelka 
et al. 2007). 
Studies on Xenopus Nek9 orthologue (XNercc1) showed that endogenous 
XNercc1 in meiosis egg extracts can be coimmunoprecipitated with γ-tubulin (Roig et 
al. 2005). Immunodepletion of XNercc1 from egg extracts leads to delayed spindle 
assembly, abnormal spindles and microtubule structures. After immuno-depletion, 
aster assembly induced by RanGTP became slower and produced Ran-asters with 
abnormal size and morphology. Based on these, Nek9 were considered to be involved 
in both centrosome and spindle organization. Moreover, recent studies revealed that 
Nek9 could function in interphase progression through interaction with FACT (a 
chromatin structure modulator) localized in nucleus, and binding to chromatin (Tan 
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and Lee 2004). 
Nek11, on the other hand, may have roles in S phase (Noguchi et al. 2004). As a 
nucleolus protein, Nek11 can be activated by Nek2A in G1/S-arrested cells (Noguchi 
et al. 2004). Some evidences suggest that active Nek2A can release Nek11 from 
autoinhibition. Nek11 is autoinhibitory when its N-terminal catalytic domain 
associates with the C-terminal domain. In addition, Nek11 can associate with 
phosphorylated Nek2A but not with Nek2A kinase-dead mutant (Noguchi et al. 2004). 
Recently Nek11 was shown to be required for DNA damage-induced G2/M arrest. 
Depletion of Nek11 can prevent degradation of CDC25A. CHK1 (checkpoint kinase 1) 
was shown to activate Nek11 by phosphorylating the Ser273 residue. Activated 
Nek11 in turn phosphorylates CDC25A, and as a result regulates CDC25A 
degradation. All these suggest that genetic mutants of Nek11 may contribute to the 
development of cancer (Melixetian et al. 2009). 
Taken all information together, most of the Neks play important roles in 
regulating cell cycle but may have functions in different phases of cell cycle. Some 
members of Neks can associate with each other to form a signaling cascade, for 
example, Nek9 and Nek6/7. Current studies on Neks revealed that they have various 
functions in cell regulation, not limited in the area of cell cycle. The divergent cellular 
functions of Neks are possibly due to their various domains in the C terminus, in 
addition to the homologous kinase domain in the N-terminus. 
 
1.2 NIMA related kinase 8 (Nek8) 
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1.2.1 Sequence and molecular structure of Nek8 
Most members of Nrk kinase family were identified only recently, their precise 
functions are largely unclear. Among the twelve members of Nek protein family, 
Nek8 is little characterized. Nek8 contains a conserved N-terminal serine/threonine 
kinase domain and a C-terminal RCC1-like domain, which also exist in Nek9. 
Compared to Nek9, Nek8 lacks the coiled-coil domain. Murine Nek8, with 698 amino 
acids, was identified through a single mutation linked to polycystic kidney disease 
(PKD) in mice (Liu et al. 2002). The human homolog of Nek8 was then isolated from 
a primary human colon cDNA library, whose ORF (Open Reading Frame) encodes a 
692 amino-acid protein with a predicted molecular weight of 75kDa (Bowers and 
Boylan 2004). Sequence similarity between human Nek8 (hNek8) and murine Nek8 
(mNek8) is as high as 99%. Thus, the function information of Nek8 in mice can most 
likely be applied to Nek8 in human.  
The sequence of Nek8 is highly homologous to many known kinases and 
contains all of the required motifs for a functional kinase (Bowers and Boylan 2004), 
but the downstream substrates of Nek8 have not yet been identified. Studies on kinase 
activity using β-casein as a general substrate showed no activity, suggesting that Nek8 
may have specific substrates.  
 
1.2.2 Functions in cellular regulation and diseases of Nek8 
Murine Nek8 was first identified because of a mutation of this protein 
(Nek8G448V) in jck (juvenile cystic kidney) mice, a mouse model of the autosomal 
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recessive polycystic kidney disease (ARPKD) (Liu et al. 2002). Polycystic kidney 
disease has two different types: the autosomal dominant (ADPKD) and autosomal 
recessive (ARPKD) polycystic kidney diseases. Focal renal cysts are evident and the 
renal cystic disease is progressive in jck mice (Atala et al. 1993). Expression of 
mutated Nek8 (jck or kinase-deficient form) can lead to enlarged and multinucleated 
cells with abnormal actin cytoskeleton. Consistently, Nek8 knockdown in Zebrafish 
by morpholino anti-sense olignucleotide derived from Nek8 sequences causes 
formation of pronephric cysts (Liu et al. 2002). These studies suggested that loss of 
Nek8 function led to polycystic kidney disease. In IMCD3 cells, Nek8 was restricted 
to the proximal region of the primary cilia. However, siRNA knockdown of Nek8 did 
not affect cilia assembly (Mahjoub et al. 2005). Nek8 showed puncturate pattern of 
expression in primary cilia of WT primary mouse kidney epithelial cells. In contrast, 
Nek8 was only detected in cytoplasm and perinucleus but not in cilia of jck cells 
(Smith et al. 2006). Embryonic cells derived from jck mice display larger cystic area 
and altered cell junction than the normal cells, similar to ADPKD epithelia (Natoli et 
al. 2008). Moreover, Nek8 was found localized in the primary cilia and interact with 
polycystin-2. In jck mice, the transcriptional and protein level of polycystin-1 and 
polycystin-2 could be detected, and abnormal phosphorylation of polycystin-1 could 
also be observed (Sohara et al. 2008). Therefore Nek8 can be possibly involved in the 
signaling pathways of polycystins and then regulate cilia formation, subsequently 
have a role in the kidney disease.  
Recent studies revealed Nek8 can also be involved in another autosomal 
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recessive kidney disease, Nephromophthisis (NPHP9) (Otto et al. 2008). Several 
mutants (L330F, H425Y and A497P) of Nek8 were found in human patients samples. 
Overexpression of all these three mutants in IMCD3 cells showed defect in ciliary 
localization, while did not affect overall ciliogenesis, mitosis, or centriole number 
(Otto et al. 2008).    
The mRNA expression profile of Nek8 in normal human tissues showed that 
Nek8 level was highest in thyroid, adrenal gland and skin, relatively low in spleen, 
colon and uterus. In addition, Nek8 level in breast tumors is higher than that in normal 
human breast tissue, which indicates that Nek8 may be a tumor associated gene 
(Bowers and Boylan 2004). Although most family members are regarded as cell cycle 
regulator, it is not clear whether Nek8 participates in cell cycle regulation. Expression 
of Nek8 kinase-deficient mutant results in a decrease in actin protein, and a small 
increase in the level of Cdk1/cyclinB1 in U2OS cells (Bowers and Boylan 2004). The 
data indicated that Nek8 may be involved in G2/M progression.  
In summary, Nek8 is a potential tumor-associated gene and it is related to 
polycystic kidney disease. However, the detailed mechanisms of Nek8 in these 
diseases are far from clear. Functional studies on Nek8 are necessary and important. 
 
1.3 Involvement of Nek8 in cellular processes  
To date, no binding partner of Nek8 has been identified except polycystin-2. 
Signaling pathways that Nek8 is involved are yet to be discovered. Bioinformatics 
analysis of Nek8’s molecular structure and the available information of NIMA-related 
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kinase family can help us to predict which cellular processes that Nek8 may 
participate in. Our available data in Nek8 study indicate that Nek8 may have roles in 
cellular events involving Ran and ER-stress induced apoptosis. Thus some 
background information about these cellular events is provided as below.  
 
1.3.1 Signaling network related to RCC1-like domain and Ran 
1.3.1.1 RCC1 and RCC1 superfamily  
Nek8 contains a RCC1-like domain (RLD) in the C-terminal region, which is a 
350-500 residue domain characterized by several repeats (usually seven) each with 
51-68 amino acids. The RCC1-like domain was firstly identified in RCC1 protein 
(regulator of chromosome condensation-1) (Furuno et al. 1991). Later these 
conserved repeats were found in several mammalian proteins. At least 16 human 
proteins containing RCC1-like domain have been identified, which constitute the 
RCC1 superfamily. According to the different functional domains in these proteins, 
the RCC1 superfamily is divided into several groups: the RCC1 subgroup, the HERC 
subgroup, the RCBTB subgroup, the kinase subgroup and the miscellaneous subgroup 
(Hadjebi et al. 2008). 
    RCC1 protein is a representative of the RCC1 subgroup. In this subgroup, the 
RLD repeats span the whole protein. A single point mutation of RCC1 in hamster 
kidney tsBN2 cells can cause G1 or S phase arrest and premature chromosome 
condensation (Ohtsubo et al. 1987). The human homolog of RCC1 was characterized 
as a nuclear chromatin-associated protein. Further studies showed that RCC1 can 
                                                                          Chapter 1 Introduction                    
                                              18
interact with a Ras-related GTPase, Ran, and catalyze guanine nucleotide exchange 
upon it. Thus RCC1 is regarded as a guanine nucleotide exchange factor (GEF) of 
Ran. Ran itself has low intrinsic hydrolysis and nucleotide dissociation rates. RCC1, 
as a GEF, can induce rapid dissociation of nucleotide from Ran (more than five fold 
of magnitude) and thus allow fast activation of its GTP-bound form (Bischoff and 
Ponstingl 1995). RanGTP is essential for several cellular processes: 
nucleocytoplasmic transport, spindle formation and nuclear envelope reassembly 
(Muhlhausser and Kutay 2007; Clarke and Zhang 2008; Kalab and Heald 2008). The 
detailed mechanism of RanGTP during these cellular processes will be discussed 
later.  
The crystal structure of RCC1 protein has already been solved, which can help us 
to better understand the regulation of RCC1. RCC1 contains seven RLD repeats and 
an N-terminal NLS (nuclear localization signal). The crystal structure of RCC1 
contains a seven-bladed β-propeller and each blade corresponds to a RLD repeat 
(Renault et al. 2001). The blade consists of a four-stranded antiparallel β-sheet. 
Moreover, the N-terminal and C-terminal tails are located in the same side of the 
propeller. The N-terminal tail is flexible and extends beyond the core propeller 
structure. Later the crystal structure of the complex with RCC1 and Ran provides a 
view about the interaction between RCC1 and Ran (Nemergut et al. 2001). Each 
propeller in RCC1 is responsible for binding to Ran.  
RCC1 can associate with chromatin throughout the cell cycle. The N-terminal 
NLS of RCC1 seems responsible for this association, because RCC1 mutant with 
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NLS depletion will not bind to chromatin. Later, it was found that RCC1 can bind to 
histones, H2A and/or H2B (Nemergut et al. 2001). Association of RCC1 and 
chromatin can be modulated by Ran because RCC1D182A mutant, which can not bind 
to Ran, shows reduced binding affinity to chromatin. This mutant can also mislocalize 
RCC1 and perturb mitosis, suggesting that inactive RCC1 may have a dominant 
inhibitory effect that perturbs mitosis by a mechanism other than Ran-GTP gradient 
changes.  
It has been found that phorsphorylation of RCC1 on the serine residue near or in 
the NLS, by cdc2 kinase, is necessary for generating high Ran-GTP gradient in 
nucleus (Li and Zheng 2004). The serine11 in RCC1 is phosphorylated by cdc2 in 
vitro (Horiike et al. 2008). The association of RCC1 with chromatin can be regulated 
by posttranslational modification on RCC1 (Chen et al. 2007). Chen et al. showed 
that N-terminal serine or proline residue of RCC1 can be methylated. This 
methylation requires removal of the initiating methionine and the presence of proline 
and lysine at position 3 and 4. The methylation-defective mutant will decrease the 
binding affinity of RCC1 with chromatin in mitosis, thus cause the spindle defect. 
Chen et al .also found that the body of RCC1 interacts with H2A and H2B while the 
N-terminal methylated tail interacts across DNA (Chen et al. 2007). Since the affinity 
of RCC1 with histones decreases when apo-Ran binds nucleotide, the tail may help to 
retain RCC1 on chromosomes during nucleotide exchange on Ran. Thus RCC1 
N-terminal methylation is a crucial post-translational modification preventing 
catastrophic genetic stability in mammalian cells.  
                                                                          Chapter 1 Introduction                    
                                              20
In summary, RCC1 can associate with Ran and chromatin thus helps to maintain 
high RanGTP gradient in nucleus and stabilize the chromatin and spindle during 
mitosis. Some other RLD proteins can also function in mitotic regulation and 
associate with chromosome. TD60 is a member of the chromosome passenger 
complex (CPC) and is essential during the progression from prometaphase to 
metaphase. TD60 is required for Aurora B activation and important for proper 
alignment of chromosomes on the metaphase plate (Mollinari et al. 2003). Moreover, 
TD-60 prefers to binding with the nucleotide-free form of Rac1, indicating that TD-60 
may be a Rac1-GEF. 
HERC proteins have a HECT domain and proteins containing this domain are 
suggested to be involved in transfering ubiquitin or ubiquitin-like proteins to target 
substrate (Garcia-Gonzalo and Rosa 2005). HERC1 is shown to form covalent 
thioester bond with ubiquitin in vitro, which indirectly suggests that it has the E3 
ubiqutin ligase activity. Furthermore, HERC1 can bind to phosphatidylinositol-4, 
5-bis- phosphate [PI(4, 5)P2] through its RLD. This interaction is required for this 
domain to act as a guanine nucleotide release factor for the small GTP-binding 
proteins of the ARF and Rab families (Garcia-Gonzalo and Rosa 2005).  
Nek9 and Nek8 belong to the kinase subgroup. Available functional studies of 
Nek9 and Nek8 have been discussed and theire association with Ran have been shown 
in Chapter 1.1.2 and 1.2 (Roig et al. 2002). Nek9 can act in mitotic regulation similar 
to RCC1. However, the GEF activity of Nek9 has not been reported yet.  
In the last subgroup, Alsin was reported as a GEF for Rab5 and Rab1 via 
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different domain. It is possibly involved in the control of endocytic events (Panzeri et 
al. 2006; Jayachandran et al. 2007).  
Taken all the information together, the members of RCC1 superfamily have 
divergent functions in cellular regulation. Some of the RLD containing proteins are 
able to present GEF activity. All these study on RLD can provide us valuable clues for 
functional study of Nek8.  
 
1.3.2 Ran network  
    Ran (Ras-related nuclear protein) is a small GTPase that belongs to the Ras-like 
small GTP binding protein family (Bischoff and Ponstingl 1991). Members in this 
family have an enzymatic function in common: hydrolysis of the γ-phosphate of 
guanosine triphosphate (GTP) to create guanosine diphosphate (GDP) as product. So 
we also call them as the small GTPase. Ras is the earliest to be discovered and 
originally regarded as an oncogene in that mutation of Ras is a common presence in 
human cancers. After that, many members of this superfamily have been reported. 
According to the sequence and functional similarity, they are divided into five 
subfamilies: Ras, Rho, Rac, Ran, and Arf (Wennerberg et al. 2005).           
Small GTPases have no intrinsic catalytic activation. But they show selective 
binding to other proteins in their active GTP-bound form. The nucleotide bound state 
and the activity of most GTPase is regulated by several interacting factors such as the 
GTPase activated proteins (GAP) and the GTP/GDP exchange factors (GEF). The 
GAP and GEF of Ran GTPase are RanGAP1 and RCC1 respectively. Ran can diffuse 
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freely within the cell, while RanGAP1 located in cytoplasm can activate the intrinsic 
Ran GTPase activity, leading to conversion from RanGTP to RanGDP (Bischoff et al. 
1994); and RCC1 located in nucleus can convert RanGDP to RanGTP (Bischoff and 
Ponstingl 1991). The different localization of RanGAP1 and RCC1 can thus create 
and maintain different concentration of RanGTP within the cell, so high RanGTP 
gradient is generated in nucleus. This high RanGTP gradient is a crucial factor for 
Ran to regulate several cellular processes, including nuclear transport, mitotic spindle 
assembly and post-mitotic nuclear membrane assembly. The detailed mechanism of 
Ran involved in these regulation events will be discussed below. 
 
1.3.2.1 Ran-dependent nuclear transport 
Nuclear envelope (NE) is a double lipid bilayer that surrounds the nucleus and 
encloses the genetic material in eukaryotic cells. It works as a barrier to separate the 
cytoplasm and nucleus. The double membranes in nuclear envelope are bridged by 
nuclear pore complex (NPC), which can also mediate the communication between 
cytoplasm and nucleus. Nuclear pore complexes are large multiprotein structures 
which form channels to allow diffusion of small molecules but restrict passage of 
larger molecules to those carrying specific targeting signals.  
Nuclear pores are made of nucleoporins (Nup) proteins and allow the transport of 
water-soluble molecules across the nuclear envelope. Small molecules (normally 
<40kDa) can simply diffuse through the pores. While for the proteins whose size is 
larger, they may have specific signal sequence and be transported with the help of 
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nucleoporins.  
During import from cytoplasm to nucleus, the specific signal is nuclear 
localization signal (NLS). NLSs can be recognized by members of importin (IMP, 
also known as Karyopherin) super family, which mediate nuclear transport. Importin 
can form α/β heterodimer and α subunit is responsible for recognizing NLS in the 
cargo protein. The N-terminal importinβ-binding (IBB) domain of importinα helps it 
to interact with importinβ. Importinβ has a distinct domain binding with Ran GTPase, 
and two binding sites for the hydrophobic FG repeats of certain Nups allowing the 
importin/cargo complex to dock at the distal end of the NPCs cytoplasmic filaments. 
The complex then transfers to the central channel of the NPC and translocates to the 
nucleoplasmic side. Inside the nucleus, RanGTP binds to importinβ, thus importinα 
and the cargo protein then dissociate from the complex. Importinβ with RanGTP will 
recycle back to cytoplasm, whereas RanGTP converts to RanGDP and release 
importinβ to bind to new cargos (Moore and Blobel 1994; Melchior et al. 1995; Wu et 
al. 1995). Overview of the nuclear protein import cycle is shown as Figure 1.2. 
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Figure 1.2 Overview of the nuclear protein import cycle. During nuclear import, importinβ 
(Impβ) binds to cargoes bearing NLS (indicated as NLS) in the cytoplasm and form complex 
with importinα (Impα). After the importinα/β complex passes through nuclear pores. In 
nucleus, RanGTP binds to importinβ and dissociates it from importinα. RanGTP and 
importinβ shuttle back to cytoplasm, where RanGTP is hydrolyzed by RanGAP1 and RanBP1 
to RanGDP. CAS and RanGTP bind to importinα in the nucleus and the complex shuffle back 
to cytoplasm. This complex is also dissocated by RanGAP1 and RanBP1. The polarized 
distribution of RanGTP across the nuclear envelope is maintained by RCC1 (indicated as 
RanGEF), RanGAP1 and RanBP1.   
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The export process, from nucleus to cytoplasm, occurs by an inverse pathway. In 
nuclei, the protein containing a leucine-rich nuclear export signal (NES) can be 
recognized by exportin and form the export complex together with RanGTP. After 
transport to cytoplasm, upon conversion from RanGTP to RanGDP, the cargo is 
released. To replenish Ran in nucleus, RanGDP could be transported to nucleus 
mediated by the nuclear transport factor 2 (NTF2). Several exportins have been 
characterized. Among them, exportin-1/CRM (chromosomal region maintenance) 1 is 
best studied (Yokoya et al. 1999; Chaillan-Huntington et al. 2000).  
As a small GTPase, Ran has two different bound forms: RanGTP and RanGDP. 
RanGTP is the active form of Ran and plays crucial roles in nuclear transport. As 
described before, hydrolysis from RanGTP to RanGDP is regulated by RanGAPs 
together with Ran binding proteins (RanBPs), which are located in cytoplasm (Plafker 
and Macara 2000). The conversion from RanGDP to RanGTP is regulated by 
RanGEF, for example RCC1 protein, which is always located in nucleus. The 
different localizations of Ran regulators establish the RanGTP gradient: in nucleus, 
the concentration of RanGTP is high, especially in the region near chromosome; in 
cytoplasm, the concentration of RanGTP is low while RanGDP is high. This 
asymmetry distribution of RanGTP leads to the spatial regulation of Ran so that make 
the nuclear transport work properly (Sorokin et al. 2007). 
 
1.3.2.2 RanGTP and spindle assembly  
The machinery of nuclear transport depicted above focus on the transport across 
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the nuclear membrane. While in mitosis, the nucleus of eukaryotic cells is 
disassembled. The question is raised: what happens to the nucleocytoplasmic transport 
machinery under this condition? The researchers found that Ran may regulate the 
microtubule (MT) cytoskeleton. The ratio of Ran-GTP/Ran-GDP is important for 
controlling the extent of microtubule polymerization (Kalab and Heald 2008). In vitro 
experiments showed that RanGTP can stimulate microtubule polymerization even in 
the absence of chromosomes or centrosomes (Kahana and Cleveland 1999). Studies 
on sperm heads showed a significantly greater capacity to nucleate MTs with the 
addition of RanQ69L (RanGTP mutant). Later, studies revealed that RanGTP may 
perform a similar role in both nucleocytoplsmic transport and spindle assembly. In 
interphase animal cell, the spindle assembly factors such as TPX2 and NuMA are 
imported into nucleus. During mitosis, the breakdown of nuclear envelope provides 
the opportunity that nuclear import receptors can bind to their cargos in the mitotic 
cytosol. For example, importin α and β can bind to TPX2 and NuMA in mitosis and 
those bindings can be prevented by RanGTP. It is found that RanGTP is required to 
release importinα and β from TPX2 and subsequently stimulate Aurora A activation, 
bipolar spindle assembly and microtubule nucleation. Cdk11 can help to stabilize MT 
and keep the normal spindle assembly rate (Yokoyama et al. 2008). The RanGTP 
gradient exists across the mitotic spindle with the highest concentration of RanGTP in 
chromosome and lower towards spindle poles. Since RCC1 is the GEF of Ran and 
associated with chromatin, it helps to maintain high RanGTP in the vicinity of 
chromosome and promote spindle assembly (Kalab and Heald 2008).  
                                                                          Chapter 1 Introduction                    
                                              27
1.3.2.3 RanGTP and nuclear envelope assembly 
During mitosis, the nuclear envelope (NE) breaks down and the membrane 
constituents are redistributed within the cell. At the end of mitosis, they must be 
reassembled around the chromatin to rebuild the nucleus. The NPC are assembled and 
the nucleocytoplasmic transport will restart. The researchers aim to understand the 
mechanism about the vesicles recruitment, fusion and the NPC assembly. In vitro 
experiment using X. laevis egg extracts showed that generation of RanGTP by RCC1 
and GTP hydrolysis by RanGAP1 are required for nuclear membrane fusion, and the 
concentration of RanGTP near postmitotic chromatin is required and sufficient to 
direct NE assembly (Hetzer et al. 2000; Zhang et al. 2002). Reducing the expression 
level of any components involved in Ran-GTPase cycle in C. elegans’ embryo by 
siRNA results in the extranuclear clustering of the integral nuclear envelope proteins 
(Askjaer et al. 2002; Bamba et al. 2002). These phenomena lead researchers to 
speculate the detailed mechanism that Ran functions in NE assembly (Clarke and 
Zhang 2004). RanGTP was reported to bind to chromatin through a relatively low 
affinity association with histone3 and 4 (Bilbao-Cortes et al. 2002). Moreover, 
importinβ was found to be required for the NE assembly, which can be disrupted by a 
mutation that will decrease importinβ’s affinity for nucleoporins or RanGTP, but not 
disrupted when binding to importinα (Zhang et al. 2002). Inhibition of RanGAP1 by 
antibody will reduce the vesicles binding and fusion (Zhang and Clarke 2001). These 
results lead to a model for Ran in nuclear envelope assembly: generation of RanGTP 
by RCC1 allows the association of RanGTP to chromatin (Zhang et al. 2002). Then 
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RanGTP recruits importinβ and membrane vesicles with NPC components. The 
RanGAP-mediated RanGTP hydrolysis is required for the fusion of the vesicles. This 
mechanism is distinct to the processes of nucelocytoplasmic trafficking in that the 
cargo is not involved in NE assembly.  
In summary, Ran can regulate several cellular processes and RanGTP works as 
the active form of Ran in these processes. 
 
1.3.3 Signaling network in ER-stress induced apoptosis 
Since Ran is crucial for nuclear transport pathway, several proteins shuffling 
between nucleus and cytoplasm are regulated by Ran directly or indirectly. Apoptosis 
is a biological process where nuclear trafficking plays an important role (Yasuhara et 
al. 1997). It has been found that the RanGTP gradient across nuclear membrane is 
dissipated during apoptosis (Wong et al. 2009). Several proteins involved in the 
processes of endoplasmic reticulum (ER) stress, such as some chaperon proteins and 
some unfolded protein response transducers, can also be regulated by Ran GTPase 
(Kaplowitz and Ji 2006). So here I introduce some background information about ER 
stress linked cell death.  
The endoplasmic reticulum (ER) is a cellular organelle where secretory and 
membrane proteins are synthesized and folded. If misfolded proteins are accumulated 
in ER upon certain stimuli or under pathological conditions, cellular stress will be 
induced. The response for this accumulation is called unfolded protein response (UPR) 
(Kim et al. 2008).   
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1.3.3.1 Activation of the unfolded protein response (UPR)  
    During the UPR, initially some transcriptional factors are activated and the 
expression of genes that enhance protein folding ability or ER-assisted degradation 
(ERAD) will be induced (Xu et al. 2005). This helps to clear unfolded proteins in ER 
and export them to the cytosol for degradation. Translation of mRNAs is also 
inhibited for several hours, thereby reducing the influx of new proteins into ER until 
mRNAs encoding UPR proteins are produced. Moreover, several transduction 
signaling pathways commonly linked with cellular stress can also be activated, for 
example, the mitogen-activated protein kinases (MAPK), Jun N-terminal kinase (JNK) 
and p38 MAPK pathways (Kaneko and Nomura 2003; Wu and Kaufman 2006).  
    The activation of UPR in mammalian cells is mediated by three distinct ER stress 
sensors. Inositol-requiring protein-1 (IRE1), activating transcription factor-6 (ATF6) 
and protein kinase RNA (PKR)-like ER kinase (PERK) are integral membrane 
proteins. All these proteins have an N-terminal domain in the lumen of ER and 
C-terminal cytosolic domain so that can bridge chaperon and ER proteins. The ER 
chaperon GRP78 is reported to hold the N-terminus of these transmembrane ER 
proteins. When misfolded proteins accumulate, GRP78 releases these transmembrane 
signaling proteins, allowing their oligomerization and thereby initiating the UPR (Liu 
et al. 2000; Marcu et al. 2002; Lee 2005).  
     IRE1 is a type I transmembrane protein that has both a Ser/Thr kinase domain 
and an endoribonuclease domain (Tirasophon et al. 1998). How ER luminal domain 
of IRE1 detects the misfolded proteins induced by ER stress is not fully clear. One 
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model proposed that BiP acts as a negative regulator of IRE1 activation (Bertolotti et 
al. 2000). IRE1 is inactivated when binding to BiP. The presence of misfolded 
proteins in ER lumen can induce recruitment of BiP and allow BiP to dissociate from 
IRE1, therefore triggers oligomerization of IRE1 and activates its endoribonuclease 
domain. While in another model, IRE1 can directly recognize misfolded protein, 
which binds to the oligomerized IRE1 luminal domains (Credle et al. 2005). The 
activation of IRE1 subsequently causes the cleavage of the mRNA encoding the bZIP 
transcription factor Hac1 in yeast or Xbp1 in metazoans (Back et al. 2005). The 
spliced form of XBP1 can bind to promoters of several genes involved in UPR and 
ERAD. Moreover, the cytosolic domain of IRE1 binds to the adaptor protein TNF 
receptor-associated factor 2 (TRAF2), an E3 ubiquitin ligase and an upstream 
activator of the c-Jun N-terminal Kinase (JNK) signaling pathway (Urano et al. 2000; 
Xue et al. 2005). This IRE1/Traf2 interaction is independent of Xbp1 and the 
activation of JNK pathway may lead to activation of apoptosis after ER stress. 
    ATF6 is a type II transmembrane protein with a cytosolic domain containing a 
basic-leucine zipper motif (bZIP) and a transcription activation domain (TAD) (Wang 
et al. 2000). Its luminal domain can also bind to BiP. ER stress will lead ATF6 to 
transport to the Golgi, and then cytosolic domain of ATF6 is released and translocated 
to nucleus to activate transcription of target genes, for example Xbp1. The 
transportation to the Golgi requires the dissociation of ATF6 from BiP. Calreticulin 
also binds to ATF6 and is responsible for retaining it in ER. In mammals, ATF6 has 
two forms (ATF6α and ATF6β). ATF6α can collaborate with IRE1 to induce XBP1 
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expression (Yoshida et al. 2001). ATF6β has relatively weaker transcriptional activity 
than ATF6α.Another downstream target of ATF6 is RCAN1, an endogenous inhibitor 
of calcineurin (Belmont et al. 2008). As a calcium-activated phosphatase, 
calcineurin’s substrates include Bcl-2 antagonist of cell death (BAD). 
Dephosphorylation of BAD by calcineurin can inhibit anti-apoptotic Bcl-2 family 
proteins such as Bcl-xL (Wang et al. 1999). 
    PERK is a type I transmembrane protein with a Ser/Thr kinase domain in the 
C-terminus. The dimerization and trans-autophosphorylation of PERK can activate 
the kinase domain, leading to subsequent phosphorylation and inactivation of the 
α-subunit of eukaryotic initiation factor-2 (eIF2α). EIF2α can lead to translational 
upregulation of specific mRNAs, such as ATF4 (Jiang et al. 2005). After ATF4 
translocates to nucleus, it activates the transcription of several genes involved in the 
UPR, such as genes encoding ER chaperons GRP78 and GRP94; CHOP (C/EBP 
homologous protein), GADD34 (growth arrest and DNA-damage inducible 
protein-34), and further induce autophagy. Autophagy is generally a survival 
mechanism but is also linked to induction of non-apoptotic cell death to some extent. 
Many targets of ATF4 can increase the level of chaperones, therefore restore the redox 
homeostasis and help ER to fold or degrade them. Studies on PERK-/- cells and 
knock-in cells expressing non-phosphorylatable EIF2α (Ser51Ala) have showed 
hypersensitivie to ER stress, which support the importance of PERK-initiated signals 
in protection against ER stress. 
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1.3.3.2 ER-associated cell death and survival 
The signal-transduction events during the UPR can ameliorate the accumulation 
of unfolded proteins in ER to some contents. However, this compensation to prevent 
unfolded proteins may fail under some conditions, such as the primary stimuli cause 
excessive unfolded proteins in ER so that inducing cell death. Normally apoptosis is 
regulated by caspases. But some ER-stress induced cell death can proceed without 
caspase activity, called paraptosis (Sperandio et al. 2004). Moreover, increasing cases 
indicate that ER stress can induce autophagy, a catabolic cellular program that 
promotes cell survival in many contexts but has been associated with induction of 
nonapoptotic cell death in others. 
In ER, disturbances of the calcium regulation can induce the UPR and also 
independently perturb cellular events linked with cell survival and death. The proteins 
in Bcl-2 family possibly play important roles to link ER calcium regulation with cell 
death events. Although these proteins are better known their functions in mitochondria, 
several Bcl-2 family members have been reported to modulate ER calcium 
homeostasis and to control cell death induced by reagents triggering ER stress. These 
reagents include tunicamycin (an inhibitor of N-linked glycosylation), brefeldin A (an 
inhibitor of ER-Golgi transport), thapsigargin and oxidatants. Anti-apoptotic proteins 
such as Bcl-2 and Bcl-xL reduce basal calcium concentrations in ER, whilst the 
pro-apoptotic protein BAX has opposite function. 
Caspases are cystein proteases that exist within the cell as inactive pro-forms or 
zymogens and are cleaved to form active enzymes following the induction of 
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apoptosis. Caspase-12 was the first characterized caspase which is important during 
ER stress induced apoptosis. Upon ER stress, caspase-12 cleaves procaspase-9 and 
leads to caspase-9-dependent activation of caspase-3. PERK has been described as an 
important factor involved in the process of caspases activation, through activating 
ATF4 and CHOP. CHOP can downregulate Bcl-2 and upregulate Bim, a proapototic 
BH3-only member of the Bcl-2 family. Moreover, PERK mediates an anti-apoptotic 
response by phosphorylating Nrf2, a transcriptional factor that promotes survival in 
response to ER stress.  
IRE1 can also promote apoptosis by activating the JNK pathway. IRE1, Traf2 
and ASK1 (apoptosis signal regulating kinase-1) form a complex that phosphorylates 
JNK and activates apoptosis (Nishitoh et al. 2002). As mentioned before, IRE1 can 
regulate Xbp1 splicing and activation of JNK pathway by IRE1, Traf2 and ASK1 
complex is independent from Xbp1 splicing. Further studies showed that Xbp1 
splicing is attenuated at late stage of ER stress (Zeng et al. 2009). In Drosophila, 
Xbp1 can protect the cells from photo-receptor degeneration through activating an 
anti-oxidant response and inhibiting caspase activation (Ryoo et al. 2007; Mendes et 
al. 2009). All these results suggest that Xbp1 can both protect cells against protein 
misfolding and activate specific anti-oxidant and anti-apoptotic response when cells 
are under ER stress.  
 
1.3.3.3 ER stress and diseases   
    ER stress has been linked with several diseases, for example, neurodegenerative 
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disease, diabetes, cardiac disease and cancer. There are many attempts to explore the 
mechanisms that link ER stress with diseases so that to find out some potential drugs.   
    Autopsy studies indicated that the PERK-EIF2α pathway is hyperactive in the 
brains of patients with Alzheimer’s disease, which suggests the activation of ER-stress 
(Hoozemans et al. 2005). Amyloid-β precursor protein (APP) can undergo proteolytic 
process to produce the amlyloid-β peptide, mediated by the integral membrane 
γ–secretase protease complex including Presenilin 1 (PS1). The mutated PS1 is oftern 
found in patients with Alzheimer’s disease. It weakens the IRE1α, PERK and ATF6α 
signaling, changes the ER calcium homeostasis and renders the culture neurons more 
susceptible to cell death induced by ER stress (Ghribi 2006). CHOP level is also 
found to increase (Copanaki et al. 2007). As for Parkinson’s disease, mutations in the 
ER-associated E3 ubiquitin ligase Parkin can be found in patients with juvenile-onset 
Parkinson’s disease. Overexpression of Parkin can suppress cell death induced by ER 
stress (Takahashi and Imai 2003).  
    In cancer, activation of UPR may prevent tumor cells from the increased amount 
of misfolded proteins caused by the high number of mutations and decreased supply 
of nutrients and oxygen. Hypoxia can activate PERK and its downstream effector, 
ATF4. IRE1/Xbp1 pathway is also revealed to involve in tumorigenesis and Xbp1 is 
required for tumor growth and survival.  
    In summary, studies on the regulation of ER-stress induced cell death are 
important and may provide clues for therapeutics.  
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1.4 Hypothesis and objectives 
Nek8 contains an N-terminal catalytic domain and a C-terminal RCC1-like 
domain. However the biochemical properties of Nek8 have not been characterized. 
For example, the catalytic property of Nek8 is not clear. Nek8 can not phosphorylate 
β-catenin, a common substrate of kinase. Thus substrates of Nek8 need further study. 
Nek8 is known to be responsible for automatic recessive polycystic kidney disease. 
The only known binding partner of Nek8 is polycystin-2 (Sohara et al. 2008). 
However, the detailed mechanism of Nek8 related to PKD and the signaling pathways 
that Nek8 may be involved in are largely unknown.  
This thesis will focus on the investigation of Nek8’s functions in cellular 
regulation. Since available information about the functions of Nek8 is limited, the 
results we obtained will provide new insights on the Nek8’s function and its linkage 
with the human diseases. 
Most of the NIMA-related kinase family members function as cell cycle 
regulators. The functional study of Nek8 will start from this point to investigate 
whether Nek8 can be involved in cell cycle progression. The RCC1-like domain in the 
C-terminal region of Nek8 provides the hint that RCC1-regulated protein, Ran 
GTPase is a possible binding partner of Nek8. Based on these, my thesis aims to 
characterize the biological properties of Nek8 and to further understand Nek8’s 
functions in cellular regulation. The objectives of my study are: 
z To address the biochemical property of Nek8  
z To identify the binding partners of Nek8 
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z To elucidate whether Nek8 is involved in cell cycle regulation 
z To clarify the interaction of Nek8 and Ran and explore how their association is 
related to the nuclear transport 
z To explore how Nek8 is involved in ER stress-induced apoptosis 
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2.1 Total RNA isolation and first strand cDNA synthesis 
Cells were rinsed with cold phosphaste-buffered saline (PBS) buffer (1.3M NaCl, 
70mM Na2HPO4, 30mM Na2PO4 [PH 7.4]) and total RNA were isolated using the 
TRIZOL Reagent (Invitrogen, CA, USA) according to manufacturer instructions. 
Briefly, cells grown in a 10cm culture dish were lysed in 1ml of TRIZOL Reagent and 
the cell lysate was transferred to a clean 1.5ml eppendorf tube and incubated for 5min 
at room temperature (RT). Then 0.2ml chloroform was added into the eppendorf tube. 
After shaking vigorously and incubated for 2 to 3min at RT, samples were centrifuged 
at no more than 12,000g for 15min at 4°C. Following centrifugation, the upper 
aqueous phase of the sample was transferred to a fresh tube and the total RNA was 
precipitated by mixing with 0.5ml isopropyl alcohol. The sample was incubated for 
10min at RT and then centrifuged at no more than 12,000g for 10min at 4°C. The 
RNA pellet was washed once with 1ml 75% ethanol and dissolved in RNAase-free 
water.  
After total RNA isolation, cDNA was synthesized using the SuperScript reversed 
transcirptase (Invitrogen, CA, USA) according to manufacturer instructions. The 
cDNA synthesis was primed with oligo-dT and the cDNA was stored at -20°C for 
subsequent use. 
 
2.2 DNA amplification and cloning 
Full length hNek8 cDNA was amplified by polymerase chain reaction (PCR) 
using DyNAzymeTM EXT DNA polymerase (FINNZYMES, FI) from the HeLa cell 
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cDNA using the forward primer (5'-CTAGCTAAGCTTATGGAGAAGTACGAGCG- 
G-3') and reverse primer (5'-CAAGATAGATCTTCAGGGGGGGACCGGCTC-3') 
with BamHI (forward) and BglII (reverse) restriction sites to facilitate subsequent 
cloning. The total primers used in the study of this thesis are listed in Table 2.1. A 
50ul reaction mixtures containing 10×PCR buffer, 10mM dNTP, 1U DyNAzymeTM 
EXT DNA polymerase, 3ug cDNA and 5mM forward and reverse primers were 
subjected to the following PCR conditions: initial denaturation at 95°C for 3min, 30 
cycles of PCR using the following conditions: denaturing at 95°C for 1min, annealing 
at 58°C for 2.5min, extending at 72°C for 2min; and ending with an addition of 15min 
extension at 72°C. hNek8 fragments were generated from the full-length template 
using various combinations of PCR primers with BamHI (forward) and BglII (reverse) 
restriction sites under the same cycling conditions except that Nek8K1 using the 
EcoRI (forward) and BglII (reverse) restriction sites. PCR products were separated by 
gel electrophoresis. 
DNA gel was cast using regular ultra-pure electrophoresis-grade agarose 
(Invitrogen, CA, USA). 1% (w/v) agarose was dissolved in Tris acetate EDTA (TAE) 
buffer (0.04M Tris acetate, 1mM EDTA) supplemented with ethidium bromide 
(0.5ug/ml). Samples were mixed with a suitable amount of a 6×DNA gel loading dye 
(Promega, WI, USA) and loaded alongside GeneRulerTM 1kb DNA ladder (Fermentas, 
CA). Routine DNA gel electrophoresis was performed in the same buffer and the gels 
were viewed using an ultraviolet transilluminator (UVItec Limited, UK) and 
documented using a thermal printer (Mitsubishi Corp, JP). 
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Fragments of the expected size were excised and purified using the QIAquick 
Gel Extracion Kit (QIAGEN, GE) according to manufacturer instructions. The bands 
were cut from the gel and melted at 50°C by adding 3 volumes (relative to the band 
weight) of buffer QX1 (solubilization and binding buffer) for 15min. The melting 
solution was loaded into the spin column and centrifuged at 13,000g for 1min. 
Subsequently, the column was washed by adding 0.75ml of buffer PE (wash buffer) 
followed by centrifugation. The flow-through was discarded and the PCR products 
were eluted with 20-30μl of sterile water or elution buffer (EB; 10mM Tris-Cl, pH 8.5) 
by centrifugation at 13,000g for 1min. PCR products can also be retrieved directly by 
using QIAquick PCR Purification kit (QIAGEN, GE). 5 volumes of buffer PB 
(Binding buffer) was added to the PCR sample and the mixture was added to the spin 
column. The column was centrifuged at 13,000g for 1min and washed with 0.75ml of 
buffer PE. After spinning for 1min, PCR products were eluted with sterile water or 
buffer EB from the column. 
The PCR products were cloned into the pXJ40-HA, pXJ40-GFP (gifts from Dr. 
Low BoonChuan’s lab) or p3XFLAG-CMV10 (Sigma-Aldrich, MO, USA) 
mammalian expression vectors. Before ligation, the PCR product and the vectors were 
subjected to restriction enzyme digestion with the corresponding two restriction 
enzymes whose sites added to the primers. For example, the PCR product of 
full-length Nek8 and pXJ40-HA were both digested with BamHI and BglII for 3h at 
37°C. To generate GST-tagged Nek8 construct, the PCR product of Nek8 were 
digested with EcoRI and XhoI and cloned into the vector pGEX-4T-1 (GE healthcare, 
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NJ, USA).   
The constructs of Human wildtype Ran and mutants (T24N and Q69L) in 
pGEX-4T-1 vector were obtained from a research group of Xiamen University, China. 
Ran fragments were digested with BamI and XhoI, and then subcloned into pET-32 
vector (Novagen, GE) to generate his-tagged Ran or mammalian expression vectors.  
After digestion, the samples were purified using QIAquick PCR Purification kit 
(used for the sample with Nek8 fragment) or QIAquick Gel Extracion Kit (used for 
the sample with vector) as described above. As for the ligation condition, a 10μl 
ligation mix containing 10×T4 ligase buffer, 1U of T4 ligase (Promega, WI, USA), 
50ug of insert DNA and 20ng of vector was incubated at 16°C overnight. Then the 
sample was transformed into competent E.coli strain DH5α. In detail, the ligation 
products were added into 100μl of E.coli DH5α competent cells and incubated on ice 
for 30min. The mixture was heated at 42°C for 90sec and cooled immediately on ice 
for 5min. Subsequently, 1ml LB medium was added to the tube and incubated at 37°C 
for 1h. After incubation, the solution was spinned down. The supernatant was 
discarded with only about 100μl solution left. The pellet was resuspended in the 
solution and was spread onto the LB plate supplemented with appropriate antibiotics. 
The plates were incubated at 37°C overnight. The single colonies were picked up for 
culture and plasmids were extracted. To ensure the cloning was correct, the plasmids 
were sent to sequencing. 
 
2.3 Site-directed mutagenesis 
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Full-length human Nek8 sequence was mutated K33→M using the 
QuikchangeTM Site-Directed Mutagenesis Kit (Stratagene, CA, USA) according to the 
manufacture’s protocol. The mutagenesis primers are shown in Table 2.1 as 
Nek8K33M-forward and Nek8K33M-reverse.  
 
2.4 Plasmid DNA isolation, restriction enzyme digestion and 
sequencing analysis 
    Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit (QIAGEN, GE) 
according to manufacturer instructions. The protocol is based on the alkaline lysis 
method originally described by Birnboim and Doly, 1979. In brief, 5ml overnight 
cultures of recombinant colonies were pelleted by centrifugation and resuspended in 
the cell resuspension solution (50mM Tris PH7.5, 10mM EDTA, 100μg/ml RNase A). 
The cell lysis solution (0.2M NaOH, 1% (w/v) SDS) was added to the suspension, 
mixed by inversion. Neutralization solution (1.32M KOAc) was added to the 
suspension, mixed gently and centrifuged at 13,000g to remove cell debris. The 
cleared lysate was applied to the QIAprep spin column and briefly centrifuged to aid 
passage of lysate through column. The column was washed with PE buffer (80mM 
potassium acetate, 8.3mM Tris-HCl PH 7.5, 40μM EDTA, 55% (v/v) ETOH). Excess 
PE buffer was removed by further centrifugation. The plasmid DNS was then eluted 
from the resin with 50μl of sterile water. Plasmid concentrations were calculated at 
OD260 for use in subsequent experiments and the purified DNA was stored at -20°C.  
     The sequencing reactions were carried out with the ABI PRISM® BigDyeTM 
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Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Invitrogen, 
USA). Each sequencing reaction (20μl in total) contained 2μl of Terminator Ready 
Reaction Mix (BigDye terminators), 4μl of 5×sequencing reaction buffer, 3.2μl of 
1mM sequencing primer, 200-500ng of template DNA. PCR was performed for 27 
cycles and the conditions were as followed: 96°C for 30sec, 50°C for 10sec and 60°C 
for 30sec. 
Once PCR reaction was complete, DNA products were precipitated with the 
NaOAc/ethanol mixture (2μl of 3M NaOAc, pH 4.6 and 50μl of 95% ethanol). The 
solution was mixed and incubated at room temperature for 15min followed by 
centrifugation at 13,000g for 15min. The supernatant was discarded and the pellet was 
rinsed with 70% ethanol for two times. Each time, the pellet was incubated for 5min 
and centrifuged for 5min at room temperature. Finally, the pellet was air-dried and 
dissolved in 10μl of HiDi. The samples were sent for sequencing in the sequencing 
machine (ABI377 sequencer system, Invitrogen, USA). 
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Nek8-forward-2 (RT) CCAGGACAGGAAGCTCAGCGAGTTGTATGT 
Nek8-reverse-2(RT) CCAGGGGTGCAGAGCCTAGTAGTGTGAA 
Ran- BamH1-s CTAGCTGGATCCATGGCTGCGCAGGGAGAG 
Ran-Xho1-as GTAACGCTCGAGTCACAGGTCATCATCCTC 
 
Table 2.1 Primers used for the cloning of Nek8 and Ran. The underlined nucleotides stand 
for introduced restriction sites. The nucleotides in bold indicate the mutated amino acid, 
replacing the original one. 
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2.5 Mammalian cell culture 
U2OS, 293T, MCF-7, MDA-MB-435, DM14 and HepG2 cells were cultured in 
the Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal 
bovine serum at 37°C in a humidified incubator with 5% CO2. HEL, TF-LTD and 
nomo-1 cells were cultured in RPMI 1640 medium supplemented with 10% fetal 
bovine serum at 37°C in a humidified incubator with 5% CO2. The skHEP1 cells were 
cultured in the Minimum essential medium (Eagle) in Earle's BSS supplemented with 
nonessential amino acids and 1 mM sodium pyruvate and 10% fetal bovine serum. 
IMCD-3 cells were grown in a 1:1 mixture of DMEM and Ham's F12 medium 
supplemented with 10% FBS. All the cell culture products are purchased from 
Hyclone, UT, USA.  
 
2.6 Cell-cycle synchronization in mammalian cells  
G1/S synchronization was achieved by double thymidine treatment. U2OS cells 
were grown to a subconfluent density (40-50%) and treated with 2mM thymidine 
(Sigma-Aldrich, MO, USA) for 16h. Then the cells were washed three times with 
PBS and cultured in fresh culture medium. After 10h, the cells were treated with 2mM 
thymindine for 14h. S phase synchronization was achieved by 5mM hydroxyurea 
(Sigma-Aldrich, MO, USA) for 40h. The cells were arrested in G2/M phase by 
100ng/ml nocodazole (Sigma-Aldrich, MO, USA) for 16h.  
    
2.7 Mammalian cell transfection, lysis and immunoprecipitation 
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    The cells were transfected by Effectene (QIAGEN, GE) according to the 
manufacturer’s protocol. The siRNAs were introduced into the cells by Lipofectamine 
2000 (Invitrogen, CA, USA) according to the manufacturer’s description. For Ran 
involved pull-down assays, cells were harvested in Ran lysis buffer (50mM Hepes pH 
7.4, 100mM NaCl, 5mM MgCl2, 10% glycerol, 1% Triton X-100, 1mM DTT, 
supplemented with proteinase inhibitors and phosphatase inhibitors including 
0.7µg/ml pepstatin, 0.5µg/ml leupeptin, 50µM ß-glycorophosphatase, 1mM Na3VO4). 
Other cells were harvested in M-per mammalian cell lysis buffer (Roche, Basel, CH) 
supplemented with proteinase inhibitor and phosphatase inhibitors shown above.  
The concentration of the collected cell lysates were measured using Protein 
Assay Reagents (Bio-Rad, CA, USA). The standard curve was first plotted with the 
different concentrations of BSA (1μg/μl–10μg/μl). The reaction was carried out by 
adding 1μl of the BSA standard to 799μl to sterile water. Later, 200μl of protein assay 
dye was mixed with the diluted BSA standard. After incubation at room temperature 
for 5min, the value of OD595 was read in a spectrophotometer. The graph was plotted 
with protein concentration as the X-axis and the OD595 reading as the Y-axis. After 
the graph was drawn, the protein sample was handled in the same way as the BSA 
standard and also measured at 595nm. The protein concentration of the samples was 
estimated by comparison against the standard curve. 
    To investigate the interaction between Nek8 and Ran in vivo, Hemagglutinin (HA) 
tagged wildtype Nek8 or Nek8 mutants were transfected either with FLAG tagged 
Ran or FLAG vector control. The cell lysates were collected in mammalian lysis 
                                                                Chapter 2 Materials and Methods                     
                                              47
buffer supplemented with protease inhibitors and phosphatase inhibitors. The 
centrifuged lysates supernatants were incubated with Flag-M2 beads (Sigma-Aldrich, 
MO, USA) for 3h with shaking at 4°C. Before incubation, the beads were washed 
with mammalian lysis buffer for two times first. After incubation, the beads were then 
subjected to be washed for 5 times at 8,000g. Following that, the bound proteins were 
eluted by 2×SDS loading dye and analyzed by Western blot. 
 
2.8 SDS-PAGE gel electrophoresis and Western blot analysis 
    Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels 
were cast with Bio-Rad gel casting system. The gels were composed of resolving gel 
layer and stacking gel layer. Resolving gel concentration ranged from 3-30% which 
was determined by the concentration of acrylamide/bisacrylamide. Take the example 
of 12% gel. The resolving gel contained 12% of acrylamide/bisacrylamide mixture 
(30% with a ratio of 29:1) in 0.375M Tris-HCl pH 8.8 and 0.1% SDS. The stacking 
gel contained 4% acrylamide/bisacrylamide in 0.125M Tris-HCl (pH 6.8) and 0.1% 
SDS. Polymerization was induced by the addition of 0.1% ammonium persulphate 
(APS) and 0.1% of N, N, N, N-Tetramethyl-Ethylenediamine (TEMED). Protein 
samples were mixed with 2×SDS sample buffer (100mM Tris-HCl pH 6.8; 4 % SDS; 
1% β-mercaptoethanol; 20% glycerol and 0.2% bromophenol blue) and heated at 
95°C for 15min before loading into the gel. Gel electrophoresis was carried out in 
Tris-Glycine buffer (25mM Tris-base; 192mM glycine and 0.1% SDS) at a constant 
voltage of 100V for 2-3h. 
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After SDS-PAGE, the separated proteins were transferred onto Polyvinylidene 
Fluoride (PVDF) membrane (Millipore, MA, USA). The membrane was blocked with 
5% slim milk powder diluted in 1×TBST (25mM Tris-HCl pH 7.4; 137mM NaCl; 
0.05% Tween-20) for 1h at room temperature. The membrane was washed in 1×TBST 
for 3 times and then incubated with primary antibodies at 4°C overnight. After three 
times washes in TBST, the membrane was incubated with secondary antibodies 
conjugated with horse radish peroxidase (HRP) for 1h at room temperature. All 
antibodies were diluted in 1×TBST buffer. The immunodetection was achieved by 
using Supersignal West Pico Chemiluminescent Substrate Solution (Pierce, IL, USA). 
 
2.9 Recombinant protein production in E. coli 
The expression vector encoding GST-Nek8 was transformed into E. coli strain 
BL21. The expression was induced by the addition of 0.1mM IPTG followed by 16h 
of incubation at 25°C.The cells were then harvested by centrifugation and disrupted in 
E. coli lysis buffer (50mM Tris-HCl, PH8.0, 0.1M NaCl, 1% Triton X-100, 2mM DTT, 
and 200uM PMSF) by sonication. The clarified supernatant was incubated with 
glutathione-Sepharose 4B (GE Healthcare, UK) for 3h at 4°C. The protein bounded 
beads were washed by the E. coli lysis buffer 3 times.  
The expression vectors encoding N-terminal 6×His tagged Ran, RanT24N or 
RanQ69L were transformed into E. coli strain BL21 respectively. The expression was 
induced by the addition of 0.4mM IPTG followed by 4h of incubation at 37°C.The 
cells were then harvested by centrifugation and disrupted in E. coli lysis buffer 
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(50mM Tris-HCl, PH8.0, 0.5M NaCl, 10% Triton X-100, 2mM DTT, and 200uM 
PMSF) by sonication. The clarified supernatant was incubated with Ni-NTA agarose 
(QIAGEN, GE) for 3h at 4°C, and the bound proteins were eluted with 250mM 
imidazole dissolved in E. coli lysis buffer.  
 
2.10 GST-fusion protein binding assays 
    The recombinant GST only or GST-Nek8 proteins were immobilized to 
Glutathione Sepharose 4B beads (GE Healthcare, UK). The beads were then 
incubated with the recombinant His-tagged Ran proteins at 4°C rotating for 3h. The 
beads were then washed with mammalian cell lysis buffer for 5 times at 4°C. After 
washing, the bound proteins were eluted by boiling in 2×SDS loading dye at 95°C for 
15min and subsequently analyzed by Western blot. 
    Recombinant GST-Ran fusion protein was loaded with GDP or GTPγs 
essentially as previously described with the following modifications (Tahara et al. 
2008). Purified recombinant GST-RanQ69L fusion protein immobilized on 
glutathione beads were washed with loading buffer (50mM Tris-HCl PH 7.5, 100mM 
NaCl, 0.1% Trion X-100, 1mM DTT and 10mM MgCl2) and resuspended in loading 
buffer containing 100uM GTPγs. And purified recombinant GST-RanT24N beads 
were resuspended in loading buffer containing 100uM GDP. After 30min of 
incubation at 30°C, the beads were rocked with lysate from cells overexpressing 
Nek8WT for 3h at 4°C, followed by 5 washes with Ran lysis buffer. The bound 
proteins were eluted with SDS loading dye and resolved by 10-12% SDS-PAGE gel, 
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followed by Western blot. For co-immunoprecipitation, FLAG-tagged constructs were 
overexpressed in 293T or U2OS cells. The cell lysates were then cleared by 
centrifugation at 13,000rpm for 10 min, and the resulting supernatants were incubated 
with anti-FLAG M2 affinity gel for 3-5h at 4°C. The bound proteins were then 
analyzed by Western blot. 
 
2.11 Immunostaining and confocal fluorescence microscopy 
    U2OS cells were plated on coverslips in 12-well plates before transfection. The 
cells were co-transfected with FLAG-Nek8 and HA-Ran plasmids (for example). 
After 24h, cells were washed with 1×PBS and fixed with 4% paraformaldehyde (PFA) 
for 30min at room temperature. After that, the cells were washed with 1×PBS and 
permeablized with 0.4% Trixon-100 in PBS for 5min, then blocked with 5% goat 
serum in PBS for 30min at room temperature. After washing, the cells were incubated 
with the mouse monoclonal anti-FLAG antibody and the rabbit polyclonal anti-HA 
antibody diluted in the blocking reagent buffer for 1h at room temperature. 
Subsequently, the cells were incubated with Alexa Fluor-conjugated secondary 
antibodies (Molecular Probes, Invitorgen, USA) for 1h at room temperature. After 
washing, cell nucleus 4'-6-Diamidino-2-phenylindole (DAPI) staining was then 
performed for 10min at room temperature. Finally, the coverslips were mounted with 
FluorSave reagent (Calbiochem, Merck, GE) and examined by confocal fluorescence 
microscope (Zeiss META LSM510). 
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2.12 FACS (Fluorescence Activated Cell Sorting) 
Cells were harvested, washed once with 1×PBS, and fixed in 70% ethanol over 
24h at 4°C. Fixed cells were washed once with PBS, treated with RNase (0.1mg/ml), 
and stained by propidium iodide (50ug/ml). Flow cytometric analysis was performed 
using DakoCytomation and the cell cycle profile was analyzed with the software 
Summit 4.3 (Dako Colorado, Inc., DK). 
 
2.13 FRAP (Fluorescence Recovery After Photobleaching) 
FRAP was performed using a quantifiable laser module (50mW, 488nm 
solid-state laser) and a microscope (Zeiss LSM 510 Meta) with a 63× objective lens. 
During analysis, the cells were maintained in phenol red-freeDME containing 25mM 
Hepes (Invitrogen, CA, USA) and 10% fetal bovine serum (Hyclone, UT, USA). The 
assay was performed essentially as previously described with following modifications 
(Tahara et al. 2008). The laser was focused to a diffraction-limited spot and the spot 
bleaching was performed with a single 160s stationary pulse at 100% laser power. The 
two images were acquired before the bleaching, and the images after bleaching were 
acquired in every 0.5s. Fluorescent recovery in the bleached spot was calculated using 
Excel (Microsoft) as follows: the mean intensity values at time t of a bleached spot 
(at), a non-bleached spot (bt) were determined, and the relative fluorescent recovery 
was calculated as at/bt. Each value was normalized to its value before bleaching. t1/2 
was calculated according to t1/2=In(2)/k, where k is the time constant for a single 
exponential recovery model. All recovery percentage was taken as the final plateau 
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intensity. All recovery measurements were well fitted by single exponential recovery 
kinetics (GraphPad Prism version 4.0; GraphPad Software). 
  
2.14 Antibodies and reagents 
The primary antibodies used in this study include the following: anti-FLAG 
mouse monoclonal antibodies (Sigma-Aldrich, USA), anti-HA rabbit polyclonal 
antibodies (Zymed, Invitrogen, USA), anti-His mouse monoclonal antibodies (Santa 
Cruz, CA, USA), anti-GST mouse monoclonal antibodies (Santa Cruz, CA, USA), 
anti-α-Tubulin mouse monoclonal antibodies (Santa Cruz, CA, USA), anti-GAPDH 
mouse monoclonal antibodies (Santa Cruz, CA, USA), anti-Ran rabbit polyclonal 
antibodies (Santa Cruz, CA, USA), anti-cleaved PARP mouse monoclonal antibodies 
(cell signaling, MA, USA), anti-cleaved caspase3 mouse monoclonal antibodies (Cell 
signaling, MA, USA), anti-Calnexin rabbit polycolonal antibodies (Cell signaling, 
MA, USA), anti-Nek8 rabbit polycolonal antiobodies (generated using the peptide 
sequence of HGQLGTNTRRGSRA corresponding to the sequence 590-603 in the 
C-terminal Nek8). The secondary antibodies used include the following: Alexa 
488-conjugated goat anti-rabbit antibodies, Alexa 488-conjugated goat anti-mouse 
antibodies, Alexa 568-conjugated goat anti-rabbit antibodies, Alexa 568-conjugated 
goat anti-mouse antibodies (Invitrogen, CA, US). 
The anti FLAG-M2 affinity gel, GTPγs, GDP, Leptomycin B (LMB), 
staurosporine (SP), thapsigargin (TG) and tunicamycin (TU) were purchased from 
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3.1 Identification of hNek8 
3.1.1 Isolation and sequence verification of human Nek8 
To examine functions of Nek8 during cellular regulation, we firstly cloned the 
hNek8 full-length ORF (open reading frame). Based on sequence obtained from 
NCBI database (NM_178170), primers were designed to amplify the full-length 
hNek8 from HeLa cDNA.  
The sequencing results showed that there are four amino-acids differences 
between the cloned hNek8 sequence and the one in Genbank submission as shown in 
Figure 3.1. In our hNek8 sequence, the amino acid at the position 292 threonine (T) is 
replaced by alanine (A), at the position 425 histinine (H) is replaced by arginine (R), 
at the position 625 threonine (T) is replaced by alanine (A), and at the position 671 
valine (V) is replaced by alanine (A). To rule out the possibilities that these 
“mutations” were not due to the process of PCR amplification, two other human 
cDNAs (from U2OS and 293T cells) were used as the templates to PCR hNek8. 
Identical clones with same four amino acids substitution compared with the online 
sequence were isolated. Therefore, these four amino acids can not be regarded as the 
mutations generated during PCR amplifications.  
The ORF of hNek8 was inserted into several expression vectors for further 
studies. As for the mammalian expression system, hNek8 was subcloned into 
pXJ-40-HA, pXJ-40-GFP and p3XFLAG-CMV-10 vectors. For the E.Coli expression 
system, hNek8 was inserted into pGEX-4T-1 vector.  
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Figure 3.1 Amino acid sequences alignment between Nek8 purified in this thesis and the 
hNek8 in NCBI database (NM_178170). The hNek8 sequence, purified in this study is 
named “Nek8-Template” and the sequence from NCBI is named “Nek8-NCBI”. Identical 
residues are shown in yellow and the different ones are shown in white. 
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3.1.2 Bioinfomatics analysis of hNek8 
The domain prediction of hNek8 was analyzed by online softwares provided in 
the website ExPASy. Results revealed that there is a catalytic domain in the N 
terminus of Nek8 from amino acid 4 to amino acid 258. In this region, Nek8 has the 
significant amino-acid sequence homology to the classical consensus kinase 
subdomains. Nek8 also has the typical motifs shown in serin/threonin kinases: 
Glycine-rich stretch of residues in the vicinity of a lysine residue and a conserved 
aspartic acid amino-acid residue.  
There are five predicted RCC1-like repeats in the C terminus of Nek8 as shown 
in Figure 3.2. Based on the domain prediction result of Nek8, several deleted mutants 
of Nek8 were constructed and cloned into expression vectors. The molecular 




Figure 3.2 Schematic representation of molecular structures of full-length Nek8 and 
various truncated mutants. The full-length Nek8 is shown as Nek8FL on the top; the kinase 
domain or the RCC1-like repeats of Nek8 are also shown as Nek8K1, Nek8R1 respectively. 
 
RCC1-like domain is named from RCC1 protein (Ohtsubo et al. 1987). The 
crystal structure of RCC1 is shown in Figure 3.3B. The RCC1 protein is composed of 
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seven repeats of 51-68 residues which are folded into a structure that resembles a 
seven-blade propeller (Renault et al. 1999). Figure 3.3A shows the 3D model of the 
RCC1-like repeats in Nek8 (Nek8R1) generated by online database 3digsaw. The 
arrows with colors in Figure 3.3A represent the β propellers.  
RCC1 appears as a propeller made up of seven blades, each consisting of a 
four-stranded antiparallel β-sheet (Figure 3.3B). The inner strand of the sheet locates 
along the shaft of the propeller. The arrangement and the folding of the RCC1-like 
domain in Nek8 (Figure 3.3A) are similar with the β propellers in the X-ray structure 
of RCC1 protein. All seven blades of RCC1 were reported to be responsible for 
binding to Ran (Renault et al. 2001). The structure similarity between the Nek8R1 
and RCC1 protein indicates that Nek8 may also bind to Ran. 
 
Figure 3.3 3D structure models of the RCC1-like repeats in hNek8. (A) The 3D structure 
of the RCC1-like repeats in Nek8. The model was constructed based on the online software 
3digsaw. (B) The X-ray structure of RCC1 protein (established by Renault, L. et al., 1999). 
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3.2 Characterization of hNek8 
3.2.1 Protein expression profile of Nek8 in mammalian cell lines 
The transcriptional expression profiles of Nek8 in different human tissues have 
been reported (Bowers and Boylan 2004). However, the protein level of hNek8 in 
different tissues or cell lines have not been examined due to the shortage of hNek8 
antibody. To facilitate the functional studies on Nek8, we generated a rabbit 
polyclonal anti-hNek8 antibody, specifically recognizing the RCC1-like domain of 
hNek8. To examine the specificity of this antibody, we tested endogenous Nek8 level 
in different human cell lines (Figure 3.4). A single band near the marker with 
molecular weight of 75KD can be detected in the 293T cell lysate with overexprssed 
HA tagged-Nek8 (shown as “Ctrl” panel), which is also confirmed by the 
immunobloting with HA antibody (data not shown here). It indicated that this hNek8 
antibody can specifically recognize hNek8. This single band can not be observed in 
293T cell lysate without transfection, suggesting endogenous Nek8 level in 293T cells 
is very low. Endogenous Nek8 can not be detected in MDA-MB-435 (melanoma cell 
line), DM14 (human melanoma cell line), HEL (human erythroleukemia cell line), 
TF-LTD (human erythroleukemia cell line) and nomo-1 (human acute myeloid 
leukemia cell line). However we can observe that the band can be detected in some 
other cell lines: U2OS (human osteosarcoma cell line), MCF-7 (breast cancer cell 
line), skHep1 and HepG2 (liver cancer cell line). This result shows that the protein 
level of Nek8 is low in normal human cell lines, and Nek8 is up-regulated in some 
cancer cell lines, for example, in liver cancer cell lines, suggesting that Nek8 may be 
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linked with cancers and it may play roles in the development of some organs. This 




Figure 3.4 Endogenous Nek8 level in different mammalian cell lines. Cell lysates from 
different human cell lines were subjected to Western blot against anti-Nek8 antibody. The cell 
lysates were equilibrated and each lane was loaded with 30ug total protein except for the 
lanes shown as “Ctrl” (293T cell lysate overexpressing HA-Nek8).  
 
3.2.2 Nek8 in cell cycle regulation 
Nek8 is a member of the NIMA-related kinase family. The members of this 
family share a similar N-terminal kinase domain. In addition, most of the members of 
this family are found to be involved in the cell cycle regulation. Since the functions of 
Nek8 are little known, it is necessary to characterize the cellular function of Nek8. To 
do this, firstly, the cellular localization of Nek8 was examined. We tried to use the 
Nek8 antibody to detect endogenous Nek8 cellular localization by immunostaining, 
but high background of the images prevented us from examing the cellular 
localization of endogenous Nek8. We have to detect the localization of Nek8 with the 
help of overexpressing GFP-tagged Nek8. As shown in Figure 3.5, Nek8 is mainly 
located in cytoplasm in interphase of U2OS cells. In mitotic cells, Nek8 can be 
diffusely in the whole cells except for the chromosome regions indicated by DAPI 
staining DNA. It suggested that Nek8 could not be localized in the chromosome 
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region even the nuclear membrane breaks down in mitotic phase. Nek8 is possibly a 




Figure 3.5 Localization of Nek8 in different cell cycle stages. U2OS cells were transfected 
with GFP-Nek8. 24hrs after transfection, the cells were fixed and DNA was stained with 
DAPI. The top panel shows the cell in interphase and the bottom panel shows the cell in 
metaphase. Scale bar: 10um. 
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Subsequently, to investigate whether Nek8 can influence the cell cycle, 
endogenous Nek8 protein levels at different cell cycle stages were examined. As 
shown in Figure 3.6, there is no significant change of Nek8 protein level in the cells 
arrested in G1 phase and S phase. Nocodazole treatment can arrest cells in G2/M phase. 
When U2OS cells were released from nocodazole arrestment, they entered mitosis 
and exit mitosis around four hours later. In the cells arrested by nocodazole, the cyclin 
B1 level is high. During the 3.5hrs after nocodazole release, the cyclin B1 level 
decreased which indicated the cells were actually undergoing mitosis. However, Nek8 
levels remain unchanged from 0 to 2.5hrs after nocodazole release. You may notice 
that Nek8 level in 3.5hrs after nocodazole release become lower than other timepoints, 
but this lower level is not consistent in repeated experiments, so we still regard Nek8 




Figure 3.6 Endogenous Nek8 protein level in different cell cycle stages. U2OS cells 
growing exponentially were untreated (first lane, asy) or treated with different drugs to arrest 
the cells at different cell cycle stages (lane2, G1, double thymidine treatment; lane 3, S, 5mM 
hydroxyurea treatment 40hrs; lane 4-9, cells released at indicated timepoints from nocodazole 
arrestment, 100ng/ml 18hrs). The cell extracts were analyzed by immunoblotting with the 
indicated antibodies (Nek8, Cyclin B1 or GAPDH). 
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To further examine whether Nek8 overexpression can play a role in cell cycle, we 
overexpressed GFP-tagged wildtype Nek8, kinase domain (Nek8K1) and 
kinase-deficient mutant (Nek8K33M), and then examined their cell cycle profiles. As 
shown in Figure 3.7, the cells overexpressing wildtype Nek8 show a very similar cell 
cycle profile as the cells with control GFP vector, and the cells overexpressing Nek8 
kinase-deficient mutant Nek8K33M. The cell cycle profile of the cells with Nek8K1 
was also examined and the distribution of cells in different cell cycle stages does not 
show obvious changes compared to the control cells. The statistic result is shown in 
Figure 3.7B and the detailed values are shown in Table 3. 1. The cell cycle profiles 
were also examined using the same method in U2OS cells, and similar results were 
obtained. Taken together, these results indicate that overexpression of Nek8 is not able 
to change the cell cycle profile.  
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Figure 3.7 Cell cycle profiles of cells with Nek8 or Nek8 mutants. (A) The cell cycle 
profile of 293T cells. 293T cells growing exponentially were transfected with pXJ-40-GFP 
vector, GFP-Nek8 or GFP-Nek8K33M (kinase deficient mutant), GFP-Nek8K1 (kinase 
domain) respectively. After 24hrs, the cells were fixed with 70% ethanol and analyzed by 
flow cytometry. (B)The table shows the comparative percentage of the cells in specific cell 
cycle stages. The results are calculated based on the data collected from 3 independent 
experiments. 
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 Total SubG1 G1 S G2/M 
GFP 1 0.0164 0.4844 0.1779 0.3278 
Nek8 1 0.0433 0.5503 0.1394 0.2632 
Nek8K33M 1 0.0233 0.5146 0.1530 0.3054 
Nek8K1 1 0.0174 0.4547 0.1894 0.3253 
 
Table 3.1 The comparative percentage of the cells in specific cell cycle stages. The table 
shows the mean value of cells in specific cell cycle stages represented in Figure 3.7. Results 
are calculated based on the data collected with three independent experiments. 
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3.2.3 Loss of functions of Nek8 using siRNA 
Modulating the protein level and then investigation the cell changes are the 
commonly used methods in protein functional study. In the experiments mentioned 
above, overexpressed Nek8 was used to examine general changes of the cellular 
process with excess Nek8. Alternatively, another method to modulate the protein level 
is to decrease the protein expression by siRNA techniques. A total of four siRNAs, 
which could dramatically decrease the mRNA level of Nek8, have been used and the 
treatment condition was optimized (Figure 3.8A). However, no significant reduction 
of Nek8 protein was observed even 96hrs after transfection (Figure 3.8 B). 
To find out the reason, the half-life of Nek8 was examinined using 
cycloheximide (CHX) treatment to inhibit protein synthesis. From Figure 3.9, we can 
observe that Nek8 has a much longer half-life than p53. The possible effective method 
to achieve decreased Nek8 level is to utilize long-term siRNA treatment by shRNA. 
This method can be tried in the future.  
Since it may be difficult to further decrease the low endogenous Nek8 protein 
level, functional study of Nek8 in this thesis is therefore mostly performed under the 
condition that Nek8 was overexpressed. 
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Figure 3.8 Endogenous Nek8 protein level after siRNA treatment.  
(A) mRNA level of Nek8 after siRNA treatment. U2OS cells were transfected with different 
siRNA (named as siRNA-1, 2, 3, 4) and the cell were harvested from 60hrs to 96hrs after 
siRNA transfection. Then the total RNA of the samples were extracted and subjected with 
real-time PCR using the primer pair Nek8-forward-1 (RT) and Nek8-reverse-1 (RT). Human 
GAPDH is used as the referring housekeeping gene (primers were obtained from my labmate 
Xia Yun). (B) The protein level of Nek8 after siRNA treatment. The cell lysates were 









Table 3.2 The sequences of the siRNA used. These primers were designed and synthesized by 
Invitrogen. The control siRNA with green fluorescence was purchased from Invitrogen.  
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Figure 3.9 Nek8 protein level is very stable in cells.  
(A) Endogenous Nek8 is more stable than p53 in U2OS cells. U2OS cells were treated with 
cycloheximide (CHX). The cell lysates were collected in different time points and 
immunoblotted with indicated antibodies. 
(B) The half-life of exogenous Nek8 is longer than 4hrs. 293T cells were transfected with 
FLAG-Nek8, and treated with cycloheximide (CHX) 24hrs after transfection. The cell 
lysates were collected in different timepoints after CHX treatment and immunobloted 
with indicated antibodies. 
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3. 3 Investigation of Nek8’s potential binding partners 
During the functional study of Nek8, in one hand, I aim to examine which 
cellular processes that Nek8 may be involved in, and in the other hand, to find out the 
binding partners of Nek8, so we can get a clear view how Nek8 functions in a specific 
cellular regulation. To find out the potential targets of Nek8, the binding partners of 
Nek8 was predicted based on the analysis of Nek8’s molecular structure.  
 
3.3.1 Ran is a potential binding partner of Nek8 based on the domain 
analysis 
The protein functional domains always provide unique properties so that the 
proteins sharing the similar domain may have a same binding partner. Based on this 
observation, we start to analyze the molecular structure of Nek8. As mentioned before, 
there is a RCC1-like domain in the C-terminus of Nek8. RCC1 protein was known to 
interact with Ran GTPase and their association is responsible for the process of 
nuclear import and export (Hadjebi et al. 2008). Nek9, the closest member to Nek8 in 
Nek family, was reported to with Ran and their association plays role in mitotic 
progression (Roig et al. 2002). Thus, it leads us to speculate that Nek8 may also 
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Figure 3.10 Cellular localization of Nek8 and Ran FLAG-Nek8 and HA-Ran were 
co-transfected into U2OS cells, after 24hrs, the cells were fixed with cold methanol and 
subjected to immunofluorescent staining with anti-mouse FLAG and anti-rabbit HA 
antibodies. The DNA was stained with DAPI. Scale bar: 10um. 
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3.3.2 Nek8 can interact with Ran in vitro and in vivo 
To examine whether Nek8 can associate with Ran, the cellular localization of 
Nek8 and Ran were studied (Figure 3.10). Nek8 was mainly located in cytoplasm and 
Ran was located in both nucleus and cytoplasm. The same localization of Nek8 and 
Ran in cytoplasm indicated that Nek8 had the spatial possibility to interact with Ran.  
The interaction affinity between the bacterial recombinant GST-Nek8 and 
His-Ran were examined through pull-down assay (Figure 3.11). The pull-down of 
His-Ran by GST- Nek8 not by GST itself indicate that Nek8 can bind to Ran directly 
in vitro. Thereafter, the interaction between Nek8 and Ran in vivo was examined 
(Figure 3.12). Cell lysates with overexpressed FLAG-Nek8 can pull down 
endogenous Ran (Fig. 3.12A), which shows that Nek8 can interact with Ran in vivo. 
Moreover, FLAG-Nek8 can also bind to HA-Ran (Figure 3.12B), which further 
confirmed that Nek8 can bind to Ran in vivo. To get the detailed molecular 
mechanism beneath the interaction of Nek8 and Ran, the binding affinities between 
Ran and several Nek8 truncated mutants were also studied. Both of the truncated 
mutants Nek8K1 (kinase domain) and Nek8R2 (RCC1-like domain) can pull down 
endogenous Ran (Figure 3.12A). Both Nek8K1 and Nek8R1 (RCC1-like domain) can 
pull down HA-Ran (Figure 3.12B). You may notice that the HA-Ran pulled down by 
Nek8R1 is much lower than by Nek8K1 or full-length Nek8. This is due to the low 
loading amount of Nek8R1 by FLAG-M2 beads as shown in the middle panel of 
Figure 3.12B. Taken these together, it can be concluded that Nek8 can interact with 
Ran through both the kinase domain and the RCC1-like domain. Moreover, Nek8 
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kinase-deficient mutant (Nek8K33M) still binds to Ran (Figure 3.12A), which 
indicates that the interaction between Ran and Nek8 does not rely on whether Nek8 










Figure 3.11 Nek8 binds to Ran in vitro. The E. coli lysates with overexpressed recombinant 
GST-Nek8 or GST proteins were incubated with glutathione-Sepharose beads overnight 
respectively. After washing, the beads were incubated with purified recombinant His-Ran 
protein and the bound proteins were analyzed by immunobloting with the indicated 
antibodies. 
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Figure 3.12 Nek8 binds to Ran in vivo.  
(A) Nek8 binds to endogenous Ran in vivo. The 293T cells were transfected with 
FLAG-vector or FLAG-Nek8 series proteins. After 24hrs, the cell lysates were incubated 
with FLAG-M2 beads. The immunoprecipitates (the top and middle rows) and cell lysates 
(the bottom row) were analyzed by immunobloting with indicated antibodies.  
(B) Nek8 binds to exogenous Ran. The 293T cells were cotransfected with FLAG-vector or 
FLAG-Nek8 series proteins and HA-Ran. After 24hrs, the cell lysates were incubated 
with FLAG-M2 beads. The immunoprecipitates (the top and middle rows) and cell lysates 
(the bottom row) were analyzed by immunobloting with indicated antibodies. 
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3.3.3 Nek8 prefers to bind to RanGDP 
As a small GTPase, Ran has two nucleotide-bound forms: RanGTP and RanGDP. 
These two bound forms of Ran can be exchanged and they both exist in cytoplasm 
and nucleus. RanGTP is much higher than RanGDP in nucleus, while become lower 
in cytoplasm. This RanGTP gradient is important for the trafficking between nucleus 
and cytoplasm (Clarke and Zhang 2008). Thus it is meaningful to investigate which 
nucleotide-bound form of Ran is responsible for its binding to Nek8. To examine this, 
the binding assay was performed by incubating GST-tagged RanGTP/RanGDP beads 
with cell lysates overexpressing FLAG-Nek8. The RanGTP were generated through 
purified GST-bound RanQ69L (a mutant which can not hydrolyse GTP) beads 
preloaded with GTPγs. RanGDP were generated through GST-bound RanT24N (a 
mutant which can not bind to GTP) beads preloaded with GDP. The 
immunoprecipitation result of GST-RanGTP/GDP with Nek8 showed that Nek8 could 
bind with both RanGDP and RanGTP in vitro (Figure 3.13A). However, Nek8 prefers 
to bind to RanGDP, in that the binding affinity of Nek8 to RanGDP is at least three 
times more than that of Nek8 to RanGTP. This result suggests that Nek8 can form a 
complex with either RanGDP or Ran GTP in vitro. It is known that there is a much 
higher percentage of RanGTP in nucleus while most of RanGDP molecules exist in 
the cytoplasm. Since the majority of Nek8 proteins are localized in the cytoplasm, we 
would expect that Nek8 may also prefer binding to RanGDP in vivo. As shown in 
Figure 3.13, FLAG-Nek8 can pull down HA-tagged wildtype Ran, RanT24N 
(RanGDP mutant) while not pull down HA-tagged RanQ69L (RanGTP mutant) in 
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293T cell lysates. HA-Nek8 can be pulled down by FLAG-RanT24N while barely by 
FLAG-RanQ69L in 293T cell lysates (Figure 3.13C). All these results suggest that 
Nek8 can associate with RanGDP and RanGTP based on their structures. But Nek8 
prefers to bind to RanGDP in mammalian systems due to spatial differences between 
Nek8 and Ran-GTP/GDP.    
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Figure 3.13 Nek8 prefers to bind to RanGDP.  
(A) Nek8 binds to RanGTP/GDP in vitro. The E. coli lysates expressing recombinant 
GST-Ran mutants or GST proteins were incubated with glutathione Sepharose beads 
overnight. After washing, the beads were preloaded with GTPγs (GST-RanQ69L beads) or 
GDP (GST-RanT24N beads), then incubated with 293T cell lysates overexpressing 
FLAG-Nek8. The bound proteins were analyzed with the indicated antibodies by Western 
blot. 
 
(B) Nek8 binds to RanGTP/GDP in vivo. The 293T cells were cotransfected with 
FLAG-vector or FLAG-Nek8 series proteins and HA-Ran series proteins as shown in the 
figures, after 24hrs, the cell lysates were incubated with FLAG-M2 beads. The 
immunoprecipitates (the top and middle rows) and cell lysates (the bottom row) were 
analyzed by immunobloting with indicated antibodies.  
 
(C) The 293T cells were cotransfected with FLAG-vector or FLAG-Ran series proteins and 
HA-Nek8 as shown in the figures, after 24h, the cell lysates were incubated with FLAG-M2 
beads. The immunoprecipitates (the top and middle rows) and cell lysates (the bottom row) 
were analyzed by immunobloting with indicated antibodies.  
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3. 4 Investigation of Nek8’s functions in nuclear transport 
3.4.1 Cellular localization of Nek8 and functional domains 
Nek8 contains the N-terminal kinase domain and C-terminal RCC1-like domain. 
From the Figure 3.5, it seems that full-length Nek8 is a cytoplasmic protein. Then we 
aim to investigate the cellular localization of these domains. With several Nek8 
mutants we have constructed (Figure 3.2), we examined the localization of different 
domains of Nek8 using immunofluorescence staining. As shown in Figure 3.14, 
Nek8K1 (kinase domain) is mainly localized in cytoplasm and some of it also 
localized in nucleus. Compared with full-length Nek8, more Nek8K1 can be localized 
in nucleus. However, Nek8R2 (4 RCC1-like repeats) show cellular localization 
throughout the cells but mainly in nucleus. It is interesting to explore the regulation 
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Figure 3.14 Cellular Localization of Nek8 domains. U2OS cells were transfected with 
GFP-Nek8, GFP-Nek8 kinase domain (Nek8K1) or RCC1-like domain (Nek8R2) respectively. 
After 24hrs, the cells were fixed and DNA was stained with DAPI. Scale bar: 10um. 
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3.4.2 Localization changes of Nek8 in the presence of Ran 
Nek8 can interact with Ran and prefers to bind to RanGDP form in vivo. So there 
is a question raised: what’s the effect of the association between Nek8 and Ran? Nek8 
is mostly localized in cytoplasm, while portion of this protein also localized in the 
nucleus (Figure 3.5). When examining the cellular localization of the domains of 
Nek8, we observed that RCC1-like domain can be mainly localized in nucleus 
different from full-lengh Nek8. We introduced wildtype Ran, RanGDP (RanT24N) or 
RanGTP (RanQ69L) in the cells to examine the localization changes of full-length 
Nek8 (Figure 3.15). In the cells additional with Ran or RanGDP, more Nek8 locate in 
nucleus than the cells without additional of Ran. However in the cells with RanGTP, 
Nek8 still locates in cytoplasm in majority and it accumulates in the regions 
surrounding the nucleus. We further examine the cellular localization of Nek8R2 
(RCC1-like domain) in the presence of Ran (Figure 3.16). In the cells with additional 
wildtype Ran or RanGTP, Nek8R2 loses its predominant localization in nucleus. Most 
of Nek8R2 can be translocated in cytoplasm. In the cells with additional RanGDP, 
Nek8R2 seems diffusely distributed in cytoplasm and nucleus. Taken these together, it 
is possible that Nek8’s cytoplasmic-nuclear shuffling is regulated by Ran and it is 
involved in the typical Ran transport pathway. RanGTP may be responsible for 
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Figure 3.15 Nek8 localization changes in the presence of Ran. FLAG-Nek8 and HA-Ran 
or Ran mutants were co-transfected into U2OS cells, after 24hrs, the cells were fixed and 
subjected to immunofluorescent staining with anti-mouse FLAG and anti-rabbit HA 
antibodies. The DNA was stained with DAPI. Scale bar: 10um. 
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Figure 3.16 Nek8R2 localization changes in the presence of Ran. FLAG-Nek8R2 and 
HA-Ran or Ran mutants were co-transfected into U2OS cells, after 24hrs, the cells were fixed 
and subjected to immunofluorescent staining with anti-mouse FLAG and anti-rabbit HA 
antibodies. The DNA was stained with DAPI. Scale bar: 10um. 
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3.4.3 Investigation of the effects of Ran on Nek8 in nuclear transport 
To further investigate the hypothesis that Ran will regulate nuclear shuffling of 
Nek8, the dynamics of Nek8 with or without additional Ran is investigated. The 
FRAP assay was performed to study the fluorescent recovery rate in cells with 
GFP-Nek8 and RFP-Ran or the cells with GFP-Nek8 and a control RFP vector 
(Figure 3.17). The top panel of Figure 3.17 shows the whole bleaching and recovery 
process: the fisrt two pictures were taken before bleaching; the third picture was taken 
just after bleaching and the following pictures showed the recovery progress. The 
selected bleaching regions were in cytoplasm and near the nucleus membrane because 
Nek8 always shows a high signal at that region (The red circle region of middle panel 
in Figure 3.17). After bleached at a wavelength of 488nm, the half time for recovery 
of the cells with GFP-Nek8 and RFP-Ran is 16.44s in average, which is much faster 
than that of the cells with GFP-Nek8 and RFP vector, approximately 22s. This result 
shows that in the presence of Ran, the recovery rate of the green fluorescence signals 
of Nek8 in the cells is almost 27% faster than that in the cells with a control vector 
only. Since Ran is known to be an important regulator involved in molecular transport, 
the FRAP result indicates that the association of Ran and Nek8 will stimulate the 
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Figure 3.17 Cellular dynamics of Nek8 in the presence of Ran. FRAP analysis of U2OS 
cells overexpressing GFP-Nek8 and RFP-Ran or overexpressed GFP-Nek8 and RFP vector. 
The curve shown here was generated by the values from three independent experiments.  
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3. 5 Investigation of Nek8’s functions in ER stress 
3.5.1 Cellular localization of Nek8 in ER region under stress 
    To further confirm the translocation of Nek8, we treated cells with Leptomycin B 
(LMB, an inhibitor of nuclear export) to investigate the localization of Nek8 if the 
nuclear export is blocked. Similar to the cells overexpressing RanQ69L (Figure 3.15), 
Nek8 is accumulated near the nuclear membrane (Figure 3.18). The accumulation 
region is not limited to the nucleus membrane; it is extended outside the nucleus 
membranes. The same accumulation was also observed in the cells upon the treatment 
of LMB (Figure 3.18). This region is really similar to the location of the endoplasmic 
reticulum (ER). Utilizing an ER marker calnexin (CNX), we confirmed that Nek8 is 
enriched in ER region (Figure 3.19). RanGTP gradient is important in 
nucleocytoplasmic transport and overexpression of Ran may cause the stress in cells. 
Blockage of nuclear export by Leptomycin B may also cause the stress in cells. Taken 
together, we suspected that accumulation of Nek8 in the ER region may have some 
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Figure 3.18 Cellular localization of Nek8 under LMB treatment. U2OS cells were 
transfected by FLAG-Nek8. 24hrs after transfection, the cells were treated or not treated with 
100ng/ml LMB for 4hrs, and then the cells were fixed with cold methanol and subjected to 
immunofluorescent staining with anti-mouse FLAG antibody. The DNA was stained with 
DAPI. Scale bar: 10um. 
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Figure 3.19 Nek8 could be colocalized with calnexin (CNX). FLAG-Nek8 were transfected 
into U2OS cells, after 24hrs, the cells were fixed with cold methanol and subjected to 
immunofluorescent staining with anti-mouse FLAG and anti-rabbit calnexin antibody. The 
DNA was stained with DAPI. Scale bar: 10um. 
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3.5.2 Investigation of Nek8’s changes under the ER stress 
These observations led us to hypothesize that Nek8 may play some role for the 
cellular regulation under ER stress. To examine whether Nek8 can be involved in this 
process, we treated cells with several ER-stress drugs, such as staurosporine (SP), 
thapsigargin (TG) and tunicamycin (TU) and checked whether the endogenous Nek8 
level is changed in these treated cells. Staurosporine can induce apoptosis by acting 
directly on the mitochondria (Matsuyama et al. 2000). Thapsigargin and tunicamycin 
induce apoptosis by stressing the ER (Breckenridge et al. 2003). Thapsigargin can 
inhibit Ca2+-ATPase in the ER, cause increases in the intracellular concentration of 
calcium and activate the UPR. Tunicamycin inhibit N-linked glycosylation. To our 
surprise, we observed dramatically increased Nek8 level after drug treatments along 
with the increased cleaved PARP (Figure 3.20). The cell imaging pictures showed 
accumulation of Nek8 in the ER region under these ER stress drugs (Figure 3.21). 
Although the accumulations after ER stress drugs treatment did not show more 
obviously compared with the cells just overexpressing Nek8 itself, these results still 
suggest that Nek8 is possibly involved in the cell regulation process under ER stress. 
 
3.5.3 Nek8 can delay cell proceeding to apoptosis under ER stress 
    We aimed to investigate how the change of Nek8 protein level correlates to the 
ER stress and to examine how the ER stress-induced apoptosis procedure is changed 
when manipulating the protein levels of Nek8. The U2OS cells were transfected with 
GFP or GFP-Nek8, and then treated with ER stress drugs-SP and TU respectively 
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(Figure 3.22). The cell lysates were harvested at indicated time points after drug 
treatment and probed with indicated antibodies. As shown in Figure 3.22A, we can 
observe that, 24hrs after the staurosporine (SP) treatment, the cells overexpressing 
GFP-Nek8 have lower cleaved-PARP and cleaved-caspase-3 level than those the cells 
overexpressing control GFP. Similar phenomena were observed in the cells treated 
with TU, although the differences are not as significant as that in SP treatment (Figure 
3.22). At the timepoint 0 after drug treatment, the cleavage caspase-3 and PARP can 
be detected in the cells overexpressing GFP-Nek8 not in the cells overexpressing GFP 
only, which indicate excess Nek8 may cause apoptosis. We can notice that the 
GFP-Nek8 level in the samples at the timepoint 0 is much higher compared with those 
at the timepoints 8, 12, 24 hrs. Combined with the upregulated endogenous Nek8 
upon ER stress drug treatment, it is possible that extremely high level of Nek8 will 
induce apoptosis while relatively low overexpressing Nek8 can protect cells from 
apoptosis.      
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Figure 3.20 Endogenous Nek8 increases under ER-stress drug treatment. The U2OS cells 
were treated with 100nM staurosporine (SP), 1uM thapsigargin (TG) and 10ng/ml 
tunicamycin (TU) respectively, and harvested in the indicated time points. The cell lysates 
were analyzed by immunobloting with the indicated antibodies. 
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Figure 3.21 Nek8 is prone to accumulate in ER region under the stress. FLAG-Nek8 were 
transfected into U2OS cells, after 24hrs, the cells were treated with ER stress drugs (SP, 
TU,TG respectively) and then fixed with cold methanol and subjected to immunofluorescent 
staining with anti-mouse FLAG and anti-rabbit calnexin antibody. The DNA was stained with 
DAPI. Scale bar: 10um. 
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Figure 3.22 Overexpression of Nek8 can delay cell proceeding to apoptosis under ER 
stress. (A)The U2OS cells were transfected with GFP or GFP-Nek8, and then treated with 
100nM staurosporine (SP). The cell lysates were harvested at indicated time points and 
analyzed by Western blot with indicated antibodies. (B)The U2OS cells were transfected 
with GFP or GFP-Nek8, and then treated with 10ng/ml tunicamycin (TU). The cell lysates 
were harvested at indicated time points and analyzed by Western blot with indicated 
antibodies.
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3.5.4 Hsp70 is revealed as a Nek8’s binding partner based on the pull 
down assay 
As we have known that Nek8 may be involved in the ER stress pathway, it is 
natural for us to investigate how Nek8 function in this pathway, for example, which 
protein is the binding partner during this process. There are several methods to predict 
the potencial targets of a protein. Besides the prediction of the binding partner based 
on the protein’s molecular structure mentioned before, a typical method is to do pull 
down assay. In this study, I use the FLAG-M2 beads to incubate with the 293T cell 
lysate containing overexpressed FLAG-Nek8 about 4hrs and run SDS-PAGE gel after 
washing the beads for 3 times. Then the gel was subjected with silver staining (Figure 
3.23). The interested bands were cut and sent for protein sequencing. The Mass 
Spectrum result shows that it was a heat shock protein hsp70.  
To confirm that hsp70 can bind to Nek8, the 293T cells with overexpressed 
FLAG-Nek8 or Nek8 deleted mutants were incubated with FLAG-M2 beads and 
subjected to immunoprecipitation. The immunoprecipitate and the input cell lysate 
were analyzed by Western blot with indicated antibodies. As shown in Figure 3.24, 
FLAG-Nek8 can bind to endogenous hsp70 and this association is through both the 
kinase domain and RCC1-like domain of Nek8. Moreover, hsp70 could bind to two 
Nek8 mutants (kinase-deficient mutant and the jck mutant). The interaction between 
hsp70 and the Nek8 kinase-deficient mutant indicates that the association of Nek8 and 
hsp70 is also phosphorylation independent.  
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Figure 3.23 Hsp70 can be pulled down with Nek8. 293T cells were transfected with FLAG 
vector (Ctrl), FLAG-Nek8 (Nek8), FLAG-Nek8K33M (K33M) or FLAG-Nek8K1 (K1). 
After 24hrs, the cell lysates were harvested and incubated with FLAG-M2 beads. Then the 
immunoprecipitates were subjected to run SDS-PAGE gel and subsequent silver staining. The 
bands indicating on the gel were cut and sent to do MS analysis. The results show that each 
band contains the protein hsp70.  
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Figure 3.24 Hsp70 can interact with Nek8 in vivo. (A) Hsp70 can interact with Nek8 
through kinase domain. 293T cells were transfected with FLAG-vector, Nek8, Nek8K33M or 
Nek8K1. After 24hrs, the cell lysate were incubated with FLAG-M2 beads. The 
immunoprecipitate and the cell lysates were subjected to immunobloting with the indicated 
antibodies. (B) Hsp70 can interact with Nek8 through RCC1-like domain. 293T cells were 
transfected with FLAG-vector, Nek8, Nek8G442V or Nek8R1. Similar procedures were used 
as in (A). 
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3.6 Investigation of Nek8’s biological functions linked with 
disease 
    A site mutation in mouse Nek8 (G448V) can cause the polycystic kidney disease 
in jck mouse model. Thus it is interesting to investigate how Nek8 could be linked 
with this disease. Previous report has revealed that Nek8 may regulate the cilia 
formation, and then subsequently affect the downstream signaling pathway to cause 
the dysfunction of cyst in kidney (Natoli et al. 2008). As a murine inner medullary 
collecting duct cell line, IMCD3 cells can be ciliated. This cell line was hence used to 
examine how cilia formation is affected in the cells with overexpressed hNek8. The 
G442V mutant of hNek8 was constructed based on the same mutated site in jck mice. 
From the imaging pictures of Figure 3.25A, we can observe the cilia pointed by 
arrows. The cilia number in cells with Nek8 mutants (no matter the kinase deficient 
mutant or the jck mutant) is less than that in the cells with wildtype Nek8 or vector. 
These experiments were repeated three times and the cilia number were quantitated. 
The table of the statistic results is shown as Figure 3.25B. 
Overall, the biochemical and biological functions of Nek8 were characterized. 
Nek8 is mainly a cytoplasmic protein and may be not an essential regulator in cell 
cycle. Nek8 is revealed to bind to a small GTPase, Ran. Association with Ran can 
lead to translocations of Nek8 and faciliate dynamics of Nek8 in cells. Moreover, 
Nek8 could be involved in ER stress apoptosis. Overexpression of Nek8 can delay the 
apoptosis proceedings when the cells are under ER stress. The protective function of 
Nek8 is possibly regulated by hsp70. The mutation in Nek8 could cause the decreased 
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cilia number in IMCD3 cells, so Nek8 seems an important regulator in cilia formation. 
Taken together, Nek8 can be involved in several biological processes, such as nuclear 
trafficking, ER stress and cilia formation. These results about the functions of Nek8 
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Figure 3.25 Overexpression of Nek8 mutants can inhibit the cilia formation.  
(A) The imaging pictures of the IMCD3 cells. The cells were transfected with control GFP 
vector or GFP-Nek8, Nek8K33M or Nek8G442V. The cells were fixed 24hrs after 
transfection and subjected to immunostaining. The cilia were stained with acetylated 
α-tubulin. The DNA was stained with DAPI. Scale bar: 10um.  
(B) The table with statistic results from the counting of imagings of panel A. Three individual 
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Most members of NIMA-related protein kinase family are required for further 
characterization and some members have been well studied, such as Nek2. Since 
functional studies of Nek8 was little known but shown to be related to kidney disease 
and cancer, we decided to characterize the functions of Nek8. In this study, we 
identified two new binding partners of Nek8: a small GTPase Ran and a chaperon 
protein Hsp70. Thereafter, the detailed interaction mechanisms of Nek8 and Ran were 
studied. In addition, we found that the association of Nek8 with Ran can facilitate the 
nuclear-cytoplasm trafficking of Nek8. Moreover, Nek8 was found to be involved in 
the ER-stress induced apoptosis. Hsp70 could be a downstream effector of Nek8 
involving in the stress process. Our studies shed new lights on the biological functions 
of Nek8 as an important regulator involved in nuclear-cytoplasmic transportation and 
provide evidence for Nek8’s roles in ER-stress apoptosis, suggesting a possible 
mechanism that leads Nek8 to cause the polycystic kidney disease.  
 
4.1 Significance of the Nek8 domain architecture and functional 
characterization 
Nek8 has an N-terminal kinase domain and an RCC1-like domain (RLD) in its 
C-terminus. Based on the protein sequence analysis using ExPASy online software, 
we predicted the C-terminus of Nek8 have five RCC1-like repeats (Figure 3.2). With a 
high similarity to RCC1 protein, we were able to conduct a 3D structure model of 
RCC1-like domain in Nek8 as shown in Figure 3.3. The RCC1-like domain of Nek8 
forms several β-sheet propellers in which the arrangement and folding are highly 
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similar to that in the X-ray structure of RCC1 protein (Renault et al. 1998).  
RCC1 was known to interact with Ran GTPase. Their association is responsible 
for the nuclear import and export processes (Bischoff and Ponstingl 1995). With the 
RCC1-like domain, Nek8 is naturally anticipated to associate with Ran as RCC1 does. 
Several proteins with RCC1-like domain have been shown to interact with Ran, such 
as Nek9, the closest member to Nek8 among the Nek kinase family (Roig et al. 2002). 
As expected, the immunoprecipitation results show that Nek8 can associate with Ran 
both in vitro and in vivo (Figure 3.11, 12). The X-ray structure of RCC1 and Ran 
complex has revealed that the seven repeats of RCC1 can be responsible for Ran 
binding and the interaction sites for Ran and RCC1 is concentrated around the P loop 
and Switch II of RCC1 (Renault et al. 2001). Moreover the opposite side of RCC1 
binds to DNA so that RCC1 can function near centrosome (Renault et al. 1998). 
Considering the similar 3D structures of RCC1-like domain in Nek8 and RCC1, it is 
possible that the binding of Nek8 and Ran resembles that of RCC1 and Ran. To 
further characterize Nek8’s cellular function, we analyzed the detailed binding 
mechanism between Nek8 and Ran. Our results show that the four repeats close to the 
end of C terminus can bind to Ran. The N-terminal kinase domain of Nek8 can also 
interact with Ran. These findings suggest that most of the RCC1-like repeats are 
responsible for binding to Ran. From our results, we can observe that the RCC1-like 
domain of Nek8 and RCC1 protein have several properties in common, which provide 
more evidence to support the representative properties of RCC1-like repeats.  
Throughout the NIMA-related kinase family, the kinase activity of several 
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members has been characterized. β-casein, a common substrate, can be 
phosphorylated by Nek1, 2, 3, 6, 7 and Nek9 (Letwin et al. 1992; Schultz et al. 1994; 
Mitsui et al. 1999; Tanaka and Nigg 1999; Holland et al. 2002; Minoguchi et al. 
2003). Although Nek11 was not shown to phosphorylate β-casein, it can 
phosphorylate histone and myelin basic proteins which are also regarded as general 
kinase substrates. Previous study showed that the activity of Nek8 on β-casein could 
not be detected, thus Nek8 may have specific substrates different from other Nek 
members (Bowers and Boylan 2004). Nek8 possibly has kinase activity based on the 
sequence analysis of kinase domain. Nek8 has the significant amino-acid sequence 
homology to the classical consensus kinase subdomains as all other Nek family 
members. Nek8 also has the typical motifs shown in serin/threonin kinases: 
Glycine-rich stretch of residues in the vicinity of a lysine residue and a conserved 
aspartic acid amino-acid residue. We tried to examine the kinase activity of Nek8 but 
can not get positive results (data not shown). As we know, the pure protein is ideal for 
kinase assay in vitro. However, we can only use the GST-tagged Nek8 fusion beads 
for the kinase assay because it is difficult to get enough Nek8 protein for bioassay. 
Recombinant Nek8 expressed in E. coli is always localized in inclusion body so that 
the amount of soluble Nek8, which can bind to GST glutathione beads, is very low. 
For the future kinase acitivty studies on Nek8, a new kinase assay method more 
sensitive to detect signals should be utilized or the purification technique of Nek8 
need improvement to get more Nek8 protein. 
    Our biochemical studies on Nek8 have revealed the RCC1-like repeats show 
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typical protein structure as the RCC1 protein and can bind to Ran. Thus, it is 
reasonable for us to investigate the biological functions of Nek8 based on the 
available functional studies on the similar protein domains.  
 
4.2 The roles of Nek8 in cell cycle regulation 
NIMA is a well-known cell cycle regulator during mitotic phase. Similar to 
NIMA, most of the Neks have functions in the cell cycle regulation. Nek2 can 
regulate the mitotic progression as NIMA does (Fry et al. 1998). Nek9 and Nek6/7 
together can regulate the spindle assembly (Belham et al. 2003). Based on these, 
Nek8 is possible to work as a cell cycle regulator.  
Previous report only demonstrated the transcript level of Nek8 in different tissues, 
and overexpressed Nek8 can be detected in breast cancer tissues (Bowers and Boylan 
2004). With the help of polyclonal rabbit antibody specifically recognizing the hNek8, 
we can detect the protein level of endogenous Nek8 in different human cell lines 
(Figure 3.4). In most human cell lines, the endogenous Nek8 can not be detected, for 
example, HEK293T cell line. According to our studies, Nek8 can be detected in 
U2OS, hepG2, skHep1 cell lines, which indicate that Nek8 is prone to be 
overexpressed in tumor cells.  
We found that Nek8 is mainly a cytoplasmic protein and a small portion can 
locate in the nucleus (Figure 3.5). Even during mitosis when the nuclear membrane 
breaks down, Nek8 could not be localized within the area of chromosome and spindle. 
The cellular localization indicates that Nek8 has little spatial possibility to associate 
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with chromosome, centrosome or the major proteins regulating cell cycle progression, 
most of which are nuclear proteins. Endogenous level of Nek8 in the cells arrested at 
specific cell cycle stages is nearly unchanged (Figure 3.6). Moreover, overexpression 
of wildtype Nek8 or kinase-dead mutant did not alter the cell cycle profile (Figure 
3.7). Since endogenous Nek8 protein level remains constant during the whole cell 
cycle processes and manipulation of Nek8 expression level also cannot change the 
cell cycle profile, we conclude that Nek8 is not an essential cell cycle regulator.   
Nek9 is the closest member to Nek8 among Nek family. In addition to the 
N-terminal kinase domain, both of them have the RCC1-like domain. The major 
difference between them is that Nek9 has a coiled-coil domain while Nek8 does not 
have. Nek9 can be dimerized through coiled-coil domain. Auto-activation of Nek9 
could be inhibited by its dimerization. The endogenous level of Nek9 will be various 
during different cell cycle stages. Nek9 can be phosphorylated and activated in 
mitosis. Blockage of Nek9 by injecting antibody into nucleus can result in abnormal 
chromosomes (Roig et al. 2002). Although Nek9 is cytoplasmic protein whose 
localization looks almost same as Nek8, it can still regulate mitosis progression. Since 
Nek8 share functional domains and some biochemical properties with Nek9, it is 
reasonable to expect that Nek8 can also work as a cell cycle regulator.  
Overexpression of Nek8 can not change the cell cycle profile (Figure 3. 7). A 
possible reason could be the different expression level of Nek8 and Nek9. 
Endogenous Nek9 is easily detectable and much higher than Nek8 in many human 
cell lines, so the regulation of Nek8 in cell cycle is possibly masked by Nek9. We 
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tried to knockdown Nek8 by siRNA treatment, but it fails. After siRNA transfection, 
the transcription level of Nek8 was dramatically decreased while the protein level of 
Nek8 has not changed (Figure 3.8). The long half-life of Nek8 may be responsible for 
the unsuccessful depletion of Nek8 (Figure 3.9). The low but stable basal level of 
Nek8 in human cell lines suggests that Nek8 could function in cellular regulation 
although may not be essential. If some defects occur in the regulation of Nek9, Nek8 
will possibly show the ability to regulate cell cycle progression.  
 
4.3 The roles of Nek8 in nuclear transport 
With the C-terminal RCC1-like domain, Nek8 is likely a binding partner of Ran. 
Nek8 is mainly a cytoplasmic protein and Ran can be localized in both cytoplasm and 
nucleus. The localization of Nek8 and Ran enhances the spatial possibility of binding 
(Figure 3.10). Then we confirmed this hypothesis through the imumoprecipitation 
assay in vitro and in vivo (Figure 3.11 and Figure 3.12). Nek8 can interact with Ran 
through both its kinase domain and RCC1-like domain. The kinase-dead mutant of 
Nek8 can also associate with Ran, which suggests that the interaction between Ran 
and Nek8 does not rely on the phosphorylation of Ran by Nek8.  
As a small GTPase, Ran has two different nucleotide-binding forms: RanGTP 
and RanGDP. The high RanGTP gradient in nucleus is a critical factor for Ran’s 
function in cellular regulation. The high RanGDP will present in cytoplasm vice versa 
(Moore 2001). According to the cellular localization of Nek8 and Ran, it is possible 
that Nek8 will prefer to binding to RanGDP in vivo. Our data support this possibility 
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(Figure 3.13).  
Ran is an essential regulator involved in nuclear transport, mitotic spindle 
assembly and nuclear envelope assembly. Since our results have shown that Nek8 is 
not directly related to cell cycle regulation and always localized in cytoplasm, nuclear 
transport might be the most possible cellular event that Ran and Nek8 complex is 
involved in. Although the full-length Nek8 is cytoplasmic, the RCC1 domain of Nek8 
can locate in nucleus (Figure 3.14). Excess Ran or RanGDP can help more Nek8 to 
translocate to nucleus (Figure 3.15). With the addition of Ran or RanGTP, the 
RCC1-like domain of Nek8 could relocate out from nucleus (Figure 3.16). Treatment 
with the inhibitor of nuclear export regulator Crm1 will slightly increase the 
percentage of Nek8 in nucleus (Figure 3.18). These results imply that RanGTP may 
help nuclear export of Nek8 so that it leads to the major cytoplasmic localization of 
Nek8. The fluorescence recovery rate of Nek8 in the cytoplasmic area near nuclear 
membrane after bleaching is quicker in the presence of Ran than that in the presence 
of the control vector (Figure 3.17). It seems overexpressed Ran can cause more active 
dynamics of Nek8 in cytoplasm.  
    Among two different bound forms of Ran, RanGTP is the active form of Ran and 
plays crucial roles in nuclear transport. The hydrolysis from RanGTP to RanGDP is 
regulated by RanGAPs together with Ran binding proteins (RanBPs), which are 
located in cytoplasm (Plafker and Macara 2000). The conversion from RanGDP to 
RanGTP is regulated by RanGEF, for example RCC1 protein, which is always located 
in nucleus. The different localizations of hydrolysis and nucleotide exchange enzymes 
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establish the RanGTP gradient: the concentration of RanGTP is high in nucleus, 
especially in the region near chromosome; the concentration of RanGTP is low in 
cytoplasm while RanGDP is high. This asymmetry distribution of RanGTP leads to 
the spatial regulation of Ran and help determining the direction of nuclear transport 
(Sorokin et al. 2007).  
    During the conventional nuclear export process, RanGTP will form complex 
with Exportin1 and cargos in nucleus. This complex will go through the nuclear 
envelop complex (NPCs) from its nuclear side to the cytoplasm side, where the 
RanGAP1 hydrolyzes RanGTP. When RanGTP converts to RanGDP, the complex will 
dissociate and release the cargos. This process can help large molecules to transfer 
from nucleus to cytoplasm (Kohler et al. 1999). 
According to our results, the association with Ran facilitates the nuclear transport 
of Nek8. The RCC1-like domain of Nek8 is originally localized in nucleus. RanGTP 
with high concentration can bind to it and lead to the export from nucleus (Figure 
3.16). Full-length of Nek8 is mainly localized in cytoplasm and found to prefer 
binding to RanGDP (Figure 3.13). We found that Nek8 can partially translocate into 
nucleus in the presence of excess RanGDP (Figure 3.15), which is consistent with the 
previous reports that GDP with high concentration is required for nuclear import. 
Taken together, Ran can regulate the nuclear transport of Nek8. It is possible for Nek8 
to be involved in the nuclear export process. During the conventional nuclear export, 
the formation of the export cargo complex in nucleus requires a nuclear export signals 
(NES), to be recognized by the export mediators (Hutten and Kehlenbach 2006). A 
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typical NES is a leucine-rich hydrophobic peptide, which is recognized by exportin 
Crm1. The sequence searching on Nek8 can not find the signals representative in NES 
or NLS, which suggest the export of Nek8 may be independent on NES. Proteins 
lacking hydrophobic NES can also be exported to cytoplasm, but their export is 
mediated by specific exportins. This kind of transport is connected with substrate 
phosphorylation. However, we can not exclude the possibility that Nek8 has a NES 
without typical amino acids in the sequence. If there is a potential NES in Nek8, we 
can predict the possible location of NES based on the binding assay between Ran and 
Nek8 domain mutants. The NES might be located in the part closer to N-terminal of 
Nek8. As we know, Ran can interact with both the N-terminal kinase domain and 
C-terminal RCC1-like repeat. The Nek8 truncated mutant with four RCC1-like 
repeats at the C-terminus was localized in nucleus. While the mutant with only kinase 
domain was mainly localized in cytoplasm. Based on this, the potential NES is likely 
to be located within or near the kinase domain.  
We are the first to identify Ran as a binding partner of Nek8 and showed that Ran 
could regulate the nuclear transport of Nek8. However, the subsequent biological 
effects of this interaction need further study. With kinase domain and RCC1-like 
repeats, Nek9 is the closest family member to Nek8. The cellular functions of Nek9 
have been well studied, which may provide us some hints on Nek8 functional study. 
Roig et al. has found that Ran can tightly bind to the catalytic domain of Nek9 and 
also bind to RCC1-like domain of Nek9. Nek9 can be autoactivated but Ran did not 
show any impacts on the rate of autoactivation. Different from Nek8, a nuclear 
                                                             Chapter 4 Discussion and Conclusions                     
                                              108
localization singnal (NLS) was found in Nek9 as well as a coiled-coil domain. Nek9 
can homodimerize through the coiled-coil domain with inhibited state in interphase. 
The cellular localization of the domains in Nek9 showed that NLS might be 
inactivated by autophosphorylation. Upregulated Nek9 in mitosis indicated some 
factors release Nek9 from the inhibition status and the NLS can be activated. In 
mitosis, Nek9 can be localized in the vicinity of chromosome. RanGDP is speculated 
as a factor responsible for maintaining the inhibition in interphase. During mitosis, 
RanGTP gradient served as a positional marker leading the Nek9 to be localized in the 
vicinity of chromosome. For the case of Nek9, Ran might function as a regulator 
controlling the localization and activation of Nek9 and in turn have effect on the 
spindle regulation of Nek9 (Roig et al. 2002).  
In our study, Ran is also shown to control the translocation of Nek8. However, in 
contrast to help Nek9 for nuclear import, Ran facilitates the nuclear export of Nek8. 
All these observation indicate that a potential NES in Nek8 is highly possible. The 
effects for Ran on Nek8 are not related to mitotic regulation. The detailed and 
possible cellular regulation of Ran and Nek8 need further study. Future experiments 
will be explained in section 4.6. 
 
4.4 The roles of Nek8 in ER-stress induced apoptosis 
The localization of Nek8 in cytoplasm makes it different from other Nek kinase 
family members. Nek8 is not likely related to cell cycle regulation, so it is possible 
related to other cellular regulation. After carefully observing the localization of Nek8, 
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we found that the distribution of Nek8 is not equal in cytoplasm. Nek8 is prone to 
present in the region surrounding nuclear membrane than that near cell membrane 
(Figure 3.18 and 3.19). The region that Nek8 is located near the nuclear membrane is 
like where the endoplasmic reticulum (ER) is. With the help of ER marker, we 
confirmed that Nek8 can be localized in ER (Figure 3.19).  
Treatment with nuclear export inhibitor or addition of Ran can attenuate this 
asymmetry distribution of Nek8 (Figure 3.15, 18). This leads us to suspect that 
endogenous Nek8 level may change under cell stress. Thus several ER-stress induced 
drugs were used to treat cells. Western blot results showed that endogenous Nek8 
protein level increases when the cells proceed to apoptosis after treated with those 
drugs (Figure 3.20). Based on this, it is possible that Nek8 can be involved in the 
process of ER-stress induced apoptosis.  
We aim to observe the changes in the cells with ER-stress drugs treatment by 
manipulating Nek8 expression level. Firstly, we tried to decrease Nek8’s expression 
by siRNA treatment. However, no obvious protein knock-down can be obtained 
(Figure 3.8). This may due to the long half-life of Nek8 so that the working period of 
siRNA can not have effects on Nek8 (Figure 3.9). Thus we have to increase the Nek8 
protein level through transient transfection of Nek8 constructs. As shown in Figure 
3.22, the apoptosis process is delayed in the cells when expressing additional Nek8. 
The results indicate that Nek8 may prevent the cells from ER-stress induced apoptosis 
in some content. We found that cleaved caspase-3 and PARP were detectable in the 
cells overexpressing GFP-Nek8 but not in the cells overexpressing GFP vectors even 
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without drug treatment (Timepoint 0, Figure 3.22). We also noticed that the level of 
overexpressed Nek8 in timepoint 0 is much higher than that in the later timepoints. It 
seems very high level of Nek8 itself can cause stress in cells. This also can explain 
why the acculumation of Nek8 in ER region remains in all the cells overexpressing 
Nek8 with or without drug treatment (Figure 3.21).      
Endoplasmic Reticulum is an organelle in which proteins undergo 
post-translational modifications and be folded to get native conformation. The 
misfolded proteins will aggregate into insoluble structures. The protein folding in the 
ER is performed by several molecular chaperons and folding enzymes (Todd et al. 
2008). Some chaperons such as GRP78 can bind to hydrophobic regions of unfolded 
proteins and prevent them from association of proteins nearby. Other chaperons such 
as calnexin can promote the folding of glycosylated proteins. The accumulation of 
misfolded proteins can cause the ER stress and is related to several diseases. Some 
factors can cause the aggregation of misfolded proteins such as the aberration of 
calcium regulation and some stimulation agents.  
To overcome ER stress, the unfolded protein response (UPR) will be activated. 
The UPR includes several different signaling pathways: IRE1/Xbp1, ATF6 and PERK 
signaling. Then the ER-associated degradation (ERAD) will be activated to degrade 
the misfolded proteins. However, if the activation of UPR is insufficient to overcome 
ER stress, the accumulated misfolded proteins will cause the toxic effects and 
eventually lead to cell death (Todd et al. 2008). As we have found that overexpressed 
Nek8 can protect cells from ER-stress apoptosis, a question will be raised: how is 
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Nek8 actually involved in the process of ER-stress apoptosis? 
The pull-down assay assisted us to find a novel binding target of Nek8 and the 
mass spectrum sequencing results revealed that it is a chaperon protein hsp70 (Figure 
3.23). We confirmed the association of Nek8 and hsp70 by immunoprecipitation assay 
(Figure 3.24). Nek8 can interact with hsp70 through both the kinase domain and the 
RCC1-like domain. This interaction is also phosphorylated-independent. Hsp70 can 
be upregulated under stress such as heat, calcium. As a chaperon protein, it can bind 
to the misfolded proteins and prevent them from aggregation so that preventing the 
ER-stress apoptosis. Moreover, Hsp70 can directly inhibit apoptosis (Young 2010). 
One hallmark of apoptosis is the release of cytochrome c, which then recruits Apaf-1 
and dATP/ATP into an apoptosome complex. This complex then cleaves procaspase-9, 
activating caspase-9 and eventually inducing apoptosis via caspase-3 activation. 
Hsp70 inhibits this process by blocking the recruitment of procaspase-9 to the 
Apaf-1/dATP/cytochrome c apoptosome complex. Hsp70 does not bind directly to the 
procaspase-9 binding site, but likely induces a conformational change that renders 
procaspase-9 binding less favorable. Based on the available functional studies of 
Hsp70, it is reasonable for Nek8 to prevent the ER-stress induced apoptosis through 
regulating Hsp70. As mentioned above, hsp70 can be involved in several aspects 
following the ER-induced stress. The signaling pathways activated by Nek8 through 
the regulation of hsp70 have to be further ruled out. One possible model is described 
as below: since Nek8 is also localized in ER, the binding to Nek8 may help Hsp70 to 
activate its ATPase activity so that binding tightly to the misfolded proteins to prevent 
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them from aggregating together, subsequently avoid the toxic effects by misfolded 
proteins aggregation and cell death.  
Recently the researcher revealed that Ran can also be involved in apoptosis 
(Wilde and Zheng 2009). Since Nek8 can both bind to Ran and Hsp70, Ran works as 
a small GTPase and Hsp70 has the ability of ATPase. Nek8 has the potential to 
phosphorylate Ran or hsp70 and subsequently regulate the downstream molecules. 
Our in vitro kinase assay could not reveal whether Ran could work as the substrate of 
Nek8 (data not shown), thus hsp70 can be regarded as the potential substrate of Nek8. 
If Nek8 can activate hsp70, it in turn will regulate the apoptosis progress. 
 
4.5 Implications of Nek8 related to diseases 
    Nek8 has been found to be upregulated in the cancer cells so that it was 
considered as a tumor-associated protein (Bowers and Boylan 2004). As we described 
above, Nek8 can prevent cells from ER-stress induced apoptosis. This is the first time 
to provide evidences how Nek8 functions related to cancer. We found that hsp70 and 
Nek8 can work together to prevent the ER-stress induced apoptosis. This will offer us 
new hints for cancer therapy.  
To date, the confirmed disease linked with Nek8 is polycystic kidney disease 
(PKD). A site-mutation in Nek8 can be found in jck mice. At first, Nek8 was found to 
be localized in the proximal region of primary cilium in a mouse kidney epithelial cell 
line (Mahjoub et al. 2005). Later, Nek8 was shown to overexpress and loss ciliary 
localization in jck mice epithelium. Significantly longer cilia in jck mice suggested 
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Nek8 may control the cilia length (Smith et al. 2006). Nek8 mutation can affect 
ciliary and centrosomal localization in turn cause nephronophthisis (Otto et al. 2008). 
In addition, mutation in the kinase domain or the C-terminal domain of Nek8 will 
affect ciliary targeting while not the cilia length or ciliogenesis in mouse kidney 
development. Reduced ciliary expression of Nek8 could be observed in the Nek8 
mutated mice (Trapp et al. 2008).  
Another research group pointed out that Nek8 can regulate the expression and 
localization of polycystin-1 and polycystin-2, which are essential regulating proteins 
in polycystic diseases (Sohara et al. 2008). In the collecting tubules and collecting 
ducts of wildtype mice, Nek8 was localized largely in cilia and a few in the cytosol. In 
contrast, Nek8 was localized along the entire cilia in the jck mutant.  
All these can suggest that Nek8 would function in polycystic kidney disease 
through cilia regulation. However, the localization of Nek8 could not be confirmed 
with different reports. Our studies on the mouse cell line found that mutated Nek8 can 
inhibit the cilia growth (Figure 3.25), which is not consistent with the available 
reports. This may due to the difference between in vitro and in vivo enviroments.  
There is not any effective model to explain Nek8’s regulation on cilia to date. Our 
data may provide new sight on it. The cilia localization of Nek8 can be changed when 
mutated. As we know, Nek8 can interact with Ran and this interaction could facilitate 
the nuclear transport. Nek8 could protect cells from ER stress-induced apoptosis. 
Thus, our results may help to explore the linkage of Nek8 with PKD.  
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4.6 Conclusions and perspectives 
    In this study, we aim to characterize the biochemical and biological functions of 
Nek8. Ran is confirmed as the binding partner of Nek8. They can bind to each other 
in a phosphoylation-independent manner, so we can not conclude whether Ran is the 
substrate of Nek8. Nek8 is mainly located in cytoplasm, especially enriched in 
endoplasmic reticulum (ER) under stress. Ran can facilitate the nuclear transport of 
Nek8. Nek8 can also bind to Hsp70, through which they possibly prevent the cells 
from ER-stress induced apoptosis. Moreover, we found that there would be inhibition 
of cilia growth if addition of Ran and Nek8, which may provide a hint for the 
mechanism that Nek8 regulation the cilia growth and in turn involved in the PKD.  
    We make efforts to explore the functions of Nek8 and manage to reveal Nek8’s 
roles in some cellular events. However, the detailed mechanisms of Nek8 involved in 
those cellular events are required further study. There are several parts need to be 
studied:  
1. The cell phenotypes upon depletion of Nek8 protein  
If there is a mouse line with null Nek8, it will be easy to study the biological 
functions of Nek8. Endogenous Nek8 protein level is low while stable, so fully 
depletion of Nek8 may cause severe phenotypes in mouse. It’s better to generate a 
conditional knockout mouse line. However, no Nek8 knockout mouse line is available. 
The past studies on Nek8 focused on using the primary cells from jck mice, 
commercial mouse cell line which can be ciliated (IMCD3) or the samples from 
human patients. Due to our limited resources, we tried to deplete Nek8 in U2OS cells 
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by siRNA. Because of the long half-life of Nek8, siRNA treatment can not decrease 
Nek8 level. If possible, a long-time shRNA treatment can be utilized to achive the 
depletion of Nek8. Compared with phenotypes we observed through overexpressing 
Nek8, the phenotypes obtained from depleting Nek8 could provide more evidence to 
know the detailed functions of Nek8.  
 
2. Nek8 and cell cycle regulation 
We found Nek8 is mainly cytoplasmic by detecting overexpressing Nek8 with tags 
in cells. The cellular localization of endogenous Nek8 will be more accurate. However, 
our Nek8 antibody can only be used for western blot, not suitable for immunostaining. 
A Nek8 antibody with good quality may be required for further study. Moreover, the 
endogenous Nek8 level is very low while the closest homology Nek9 is abundant in 
cells. So it will be interesting to further study on whether Nek8 can regulate cell cycle 
in the background of null Nek9. 
 
3. Nek8 and nuclear transport 
From our studies, Ran can regulate nuclear transport of Nek8. The cellular 
localization of Nek8 or its domain can translocate between nucleus and cytoplasm 
when introducing RanGTP/GDP. Since all the functional studies of Nek8 are based on 
overexpressing Nek8, it may not reflect the actual situations in cells. Detection of 
cellular localization of endogenous Nek8 upon additional RanGTP/GDP can confirm 
whether our available results are correct.  
                                                             Chapter 4 Discussion and Conclusions                     
                                              116
    
4. Nek8 and ER-stress induced apoptosis 
Our results indicate that very high Nek8 level by overexpression may cause stress 
in cells. With a Nek8 antibody used for immunostaining, we can observe the changes 
of endogenous Nek8 in the cells treated with drugs inducing ER stress. These can 
make our available declaration of Nek8 to prevent cells from ER stress-induced 
apoptosis more convincing.   
 Since Hsp70 can inhibit apoptosis directly and indirectly, we can further analyze 
the possible changes of the downstream proteins. Then we can make clear what 
pathway that Nek8 and Hsp70 will be involved in and it will be beneficial for disease 
therapy.  
 
5. Nek8 in the cilia growth 
Nek8 showed different cellular localization in the jck mice compared to wildtype 
mice. Some Nek8 mutants identified from patients of polycystic kidney disease can 
also display different localization from wildtype Nek8. It would be interesting to 
examine whether Nek8 can translocate by introducing additional Ran. Further studies 
can help us to know the roles of Ran and Nek8 in cilia generation.   
 
We are the first to link Nek8 with nuclear transport and ER-stress induced 
apoptosis. Combined with previous work about the functions of Nek8 in cilia 
formation and kidney diseases, we proposed a novel view on the regulation 
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mechanism of Nek8 with diseases. In the future, with the answers for the questions 
raised above, it will have a clearer view about the biological function of Nek8 and its 
binding partners. Moreover, it would be promising to use Nek8 as a potential therapy 
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